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ABSTRACT 
Measuring cellular level phenomena is challenging because of the transparent nature of cells and 
tissues, the multiple temporal and spatial scales involved, and the need for both high sensitivity 
(to single cell density, morphology, motility, etc.) and the ability to measure a large number of 
cells.  Quantitative phase imaging (QPI) is an emerging field that addresses this need.  New 
quantitative phase imaging modalities have emerged that provide highly sensitive information on 
cellular growth, motility, dynamics and spatial organization. These parameters can be measured 
from the sub-micron to millimeter scales and timescales ranging from milliseconds to days. In 
this thesis I discuss the development and use of QPI tools and analysis methods to explore 
several applications in both clinical and research settings. Through these applications I 
demonstrate that the quantitative information provided by QPI methods allows for analyzing 
biological systems in an unprecedented manner, creating opportunities to answer longstanding 
questions in biological sciences, and also enabling the study of phenomena that were previously 
inaccessible. Here I show results on blood cell analysis, single cell growth, cellular proliferation 
assays and neural network formation. These results prove that QPI provides unique and 
important insight into the behavior of biological systems and can be utilized to help address 
important needs in clinical settings as well as answer fundamental biological questions.  
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CHAPTER 1. INTRODUCTION 
“It is very easy to answer many of these fundamental biological 
questions; you just look at the thing!” - Richard Feynman, There is 
plenty of room at the bottom, 1959.* 
The fields of cell biology and microscopy emerged simultaneously in the 17th century, when van 
Leeuwenhoek first used a light microscope to observe microscopic objects such as bacteria and 
human cells.  Since their inception, these two fields have contended with two major issues:  poor 
optical contrast, because of the thin and optically transparent nature of cells, and diffraction 
limited resolution. The  lower limit on the spatial  resolution of images is approximately half the 
wavelength of the illumination light, as first calculated by Abbe in 1873 [1]. Several approaches 
have been developed to circumvent this resolution limit, but all have practical limitations and 
severe tradeoffs between resolution and throughput. Efforts to improve optical contrast include 
engineering exogenous contrast agents and exploiting the optics of the light-specimen interaction 
to better reveal the endogenous contrast provided by naturally occurring structures [2].  
Currently, the most commonly used exogenous contrast technique in cell biology is 
fluorescence microscopy, which allows specific structures to be labeled and provides optimal  
contrast [3]. A key development in fluorescence microscopy was to genetically engineer the cell 
to express fluorescent proteins [4], essentially combining the intrinsic and exogenous contrast 
imaging fields. The advent of this technology made it possible to genetically modify a cell to 
naturally express GFP and bind the cell to prescribed cellular structures. Despite its ubiquitous 
use in biology, fluorescence imaging has several well characterized disadvantages, such as 
phototoxic effects, photo-bleaching and the need for expensive optical sources and filters. 
                                                            
* Although in this quote Feynman is referring to building more powerful electron microscopes, the sentiment of how 
important visualization is to biological sciences resonates with the topic of this thesis. 
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For endogenous contrast imaging, there are currently two widely used methods,  
differential interference contrast (DIC or Nomarski) and phase contrast [3]. Both of these 
techniques rely on the realization by Abbe that image formation, and thus contrast generation, is 
caused by interference between scattered and unscattered light fields [1]. This concept  allowed 
Zernike to develop phase contrast microscopy [5]. Phase contrast improves the contrast of an 
image by introducing a quarter-wavelength shift between the light scattered by the specimen and 
the unscattered light. Phase contrast has enabled many exciting live cell imaging studies and 
earned Zernike the 1953 Nobel Prize in Physics; however, the information provided by this 
method is qualitative and the spatial resolution is diffraction limited.  
It has become increasingly clear that an elucidation of cellular function requires the 
measurement of cellular activity with high resolution, in three dimensions, across a wide range of 
spatial and temporal scales, and in a minimally invasive manner. This multi-scale capability is 
essential, since the emergent cellular behavior is the result of integrating information from intra-
cellular molecular reactions, inter-cellular interactions, and myriad environmental stimuli. The 
response to these cues also has different implications at various scales. At the cellular level, 
changes may be observed in the growth rate, in the cell cycle, morphology, or motility or in 
various inter-cellular processes, such as the production of a certain protein. At the level of the 
cellular culture or population, changes may be observed in the overall proliferation rate, shifts in 
homeostasis points, spatial architecture, etc. Thus, to truly understand cellular behavior, there is a 
need for a measurement method that can quantify all these parameters simultaneously, across all 
relevant spatial and temporal scales.  
Quantitative phase imaging (QPI) techniques have shown the potential to address this 
need [2, 6]. In QPI, both image contrast and resolution are improved by measuring the phase 
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shift of light travelling through a biological specimen [6]. Additionally, measuring the phase 
provides quantitative data on several fundamental optical properties of living cells and tissues 
[2]. The QPI field has been growing rapidly over the past decade and a variety of methods have 
been developed [2, 7-11]. Recently we have developed a new QPI modality known as Spatial 
Light Interference Microscopy (SLIM) [12]. SLIM is a broadband (white light) illumination 
technique that provides phase sensitive measurements of thin transparent structures with 
unprecedented sensitivity [13, 14], femtogram sensitivity to changes in dry mass, and excellent 
depth sectioning capabilities which enable tomographic imaging [15]. Furthermore, SLIM is 
designed as an add-on module to a commercial phase contrast microscope providing the 
capability to simultaneously use existing modalities such as fluorescence imaging and to 
leverage existing peripheral technologies such as environmental controls for extended live cell 
imaging. 
In this thesis I demonstrate the potential of QPI technology through several applications. 
The thesis is organized as follows: In Chapter 2 the principles behind QPI are discussed and 
diffraction phase microscopy (DPM) and spatial light interference microscopy (SLIM) are 
described. In Chapter 3 I discuss various analytical tools for extracting biologically relevant 
information from quantitative phase data. In Chapter 4 I show how QPI can be used as a highly 
sensitive point of care blood screening instrument. In Chapter 5 abilities for single cell growth 
measurements, including cell cycle dependent trends, are demonstrated. In Chapter 6 I show how 
the capabilities of measuring cell growth can be extended for use as a proliferation assay. In 
Chapter 7 the growth measurement capabilities are combined with analysis of spatial structure 
and mass transport to investigate neural network development. Finally, in Chapter 8 the results 
are reviewed and the future outlook of the technology is discussed.  
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CHAPTER 2. QUANTITATIVE PHASE IMAGING* 
Quantitative phase imaging (QPI) is an emerging field aimed at studying weakly scattering and 
absorbing specimens [16]. The main challenge in generating intrinsic contrast from optically thin 
specimens including live cells is that, generally, they do not absorb or scatter light significantly, 
i.e. they are transparent, or phase objects. In his theory, Abbe described image formation as an 
interference phenomenon [1], opening the door for formulating the problem of contrast precisely 
like in interferometry. Based on this idea, in the 1930s Zernike developed phase contrast 
microscopy (PCM), in which the contrast of the interferogram generated by the scattered and 
unscattered light, i.e., the image contrast, is enhanced by shifting their relative phase by a quarter 
wavelength and further matching their relative power [17, 18]. PCM represents a major advance 
in intrinsic contrast imaging, as it reveals inner details of transparent structures without staining 
or tagging. However, the resulting phase contrast image is an intensity distribution, in which the 
phase information is coupled nonlinearly and cannot be retrieved quantitatively.  
 Gabor understood the significance of the phase information and, in the 1940s, proposed 
holography as an approach to exploit it for imaging purposes [19]. It became clear that knowing 
both the amplitude and phase of the field allows imaging to be treated as transmission of 
information, akin to radio communication [20].  
 In essence, QPI combines the pioneering ideas of Abbe, Zernike, and Gabor. The 
measured image in QPI is a map of pathlength shifts associated with the specimen. This image 
contains quantitative information about both the local thickness and refractive index of the 
                                                            
* This chapter is reproduced from (with some modifications and additional material) a review article: M. Mir, B. 
Bhaduri, R. Wang, R. Zhu and G. Popescu, “Quantitative Phase Imaging,” Progress in Optics, Chennai, B.V.: 
(2012), pp. 133-217.  This material is reproduced with the permission of the publisher and is available using the 
ISBN: 978-0-444-59422-8.  
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. 
structure. As discussed below QPI provides a powerful means to study dynamics associated with 
both thickness and refractive index fluctuations.  
In this chapter I review two full-field QPI methods that have proven successful in 
biological investigations. Section 2.1 provides a basic introduction to the principles of QPI and 
the main approaches: off-axis, phase-shifting, common path, white light, and their figures of 
merit. In Section 2.2 I discuss an off-axis method known as diffraction phase microscopy (DPM) 
and in Section 2.3 spatial light interference microscopy (SLIM) is discussed. Analysis of the 
measured quantitative phase information is discussed in Chapter 3.  
2.1 Principles of Full-Field QPI 
Quantitative phase imaging (QPI) deals with measuring the phase shift produced by a specimen 
at each point within the field of view. Full-field phase measurement techniques provide 
simultaneous information from the whole image field on the sample, which has the benefit of 
providing information on both the temporal and the spatial behavior of the specimen under 
investigation. Typically, an imaging system gives a magnified image of the specimen and the 
image field can be expressed in space-time as 
                                        
   
   
0
,
0
, ; , ( , )
,
i
i x y
U x y t U x y h x y
U x y e



 (2.1) 
Clearly, if the image is recorded by the detector as is, only the modulus squared of the field, 
 
2
,iU x y , is obtained, and thus, the phase information is lost. However, if the image field is 
mixed (i.e. interfered) with another (reference) field, 
RU , the resulting intensity retains 
information about the phase, 
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 
           k k r
 (2.2) 
In Eq. 2.2,   is the mean frequency, k  the mean wavevector, and   is the phase shift of 
interest. For an arbitrary optical field, the frequency spread around   defines temporal 
coherence and the wavevector spread around k  characterizes the spatial coherence of the field, 
as described earlier. We assume that the reference field can have both a delay, 
Rt , and a different 
direction of propagation along 
Rk . It can be seen that measurements at different delays Rt  or at 
different points across the image plane, r , can both provide enough information to extract  . 
Modulating the time delay is typically referred to as the phase shifting where three or more 
intensity patterns are recorded to extract . Using a tilted reference beam is commonly called the 
off-axis (or shear) method, from which phase information can be extracted from a single 
recorded intensity pattern. In some interferometric systems, the object and reference beams travel 
the same optical path; these are known as common path methods; furthermore, some systems use 
broadband white light as an illumination source and are known as white light methods. In 
practice, the phase shifting and off-axis methods are not normally used simultaneously; however, 
they are often implemented in a common path geometry or with white light illumination for 
better performance. Furthermore, phase information can also be retrieved through non-
interferometric methods, for example, by recording a stack of defocused intensity images for 
solving the transport of intensity equation (TIE).  
Like all instruments, QPI systems are characterized by certain parameters that quantify 
their performance. The main figures of merit are: acquisition rate, transverse resolution and 
phase sensitivity, both temporally and spatially. 
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Temporal sampling: Acquisition Rate 
Acquisition rate establishes the fastest phenomena that can be studied by a QPI method. 
According to the Nyquist sampling theorem (or Nyquist-Shannon theorem), the sampling 
frequency has to be at least twice the frequency of the signal of interest [21, 22]. In QPI, the 
required acquisition rates vary broadly with the application, from 100s of Hz in the case of 
membrane fluctuations to 1/1000 Hz when studying the cell cycle. The acquisition rate of QPI 
systems depends on the modality used for phase retrieval. Off-axis interferometry gives the 
phase map from a single camera exposure and is thus the fastest. On the other hand, phase-
shifting techniques are slower as they require at least 3 intensity images for each phase image 
and hence the overall acquisition rate is at best 3 times lower than that of the camera.  
Spatial sampling: Transverse Resolution 
As in all imaging methods, it is desirable to preserve the diffraction limited resolution 
provided by the microscope [23]. Defining a proper measure of transverse resolution in QPI is 
nontrivial and perhaps worth pursuing by theoretical researchers. Of course, such a definition 
must take into account that the coherent imaging system is not linear in phase (or in intensity), 
but in the complex field. 
Phase-shifting methods are more likely than off-axis methods to preserve the diffraction 
limited resolution of the instrument. In off-axis geometries, the issue is complicated by the 
additional length scale introduced by the spatial modulation frequency (i.e. the fringe period). 
Following the Nyquist sampling theorem, this frequency must be high enough to recover the 
maximum frequency allowed by the numerical aperture of the objective. Furthermore, the spatial 
filtering involving Fourier transformations back and forth has the detrimental effect of adding 
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noise to the reconstructed image. By contrast, in phase shifting, the phase image recovery 
involves only simple operations of summation and subtraction, which is overall less noisy.  
Temporal Stability: Temporal Phase Sensitivity 
Temporal stability is perhaps the most challenging feature to achieve in QPI. In studying 
dynamic phenomena by QPI, the question that often arises is: what is the smallest phase change 
that can be detected at a given point in the field of view? For instance, studying red blood cell 
membrane fluctuations requires a path length displacement sensitivity on the order of 1 nm, 
which translates roughly to a temporal phase sensitivity of 5-10 mrad, depending on the 
wavelength. In time-resolved interferometric experiments uncorrelated noise between the two 
fields of the interferometer always limits the temporal phase sensitivity; i.e. the resulting 
interference signal contains a random phase in the cross-term, 
     
2 2
1 2 1 22 cos ,I t U U U U t t          (2.3) 
where   is the phase under investigation and  t  is the temporal phase noise. If   fluctuates 
randomly over the entire interval  ,   during the time scales relevant to the measurement, the 
information about the quantity of interest,  , is completely lost, i.e. the last term in Eq. 2.3 
averages to zero. Sources of phase noise include air fluctuations, mechanical vibrations of optical 
components, vibrations in the optical table, etc. In order to improve the stability of QPI systems, 
there are several approaches typically pursued: 
 i) Passive stabilization includes damping mechanical oscillations from the system (e.g. 
from the optical table), placing the interferometer in vacuum sealed enclosures, etc. To some 
extent, most QPI systems incorporate some degree of passive stabilization; floating the optical 
table is one such example. Unfortunately, these procedures are often insufficient to ensure 
sensitive phase measurements of biological relevance. 
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 ii) Active stabilization involves the continuous cancellation of noise via a feedback loop 
and an active element (e.g. a piezoelectric transducer) that tunes the pathlength difference in the 
interferometer. This principle has been implemented in various geometries in the past with some 
success. Of course, such active stabilization drastically complicates the measurement by adding 
dedicated electronics and optical components. 
 iii) Differential measurements can also be used effectively to increase QPI sensitivity. 
The main idea is to perform two noisy measurements whereby the noise in the two signals is 
correlated and, thus, can be subtracted. 
 iv) Common path interferometry refers to QPI geometries where the two fields travel 
along paths that are physically very close. In this case, the noise in both fields is very similar and 
hence automatically cancels in the interference (cross) term.  
Spatial Uniformity: Spatial Phase Sensitivity 
Analog to the “frame-to-frame” phase noise discussed in the previous section, there is a 
“point-to-point” (spatial) phase noise that affects the QPI measurement. This spatial phase 
sensitivity limits the smallest topographic change that the QPI system can detect.  
 Unlike with temporal noise, there are no clear cut solutions to improve spatial sensitivity 
besides keeping the optics pristine and decreasing the coherence length of the illumination light. 
The spatial non-uniformities in the phase background are mainly due to the random interference 
pattern (i.e. speckle) produced by fields scattered from impurities on optics, specular reflections 
from the various surfaces in the system, etc. This spatial noise is worst in highly coherent 
sources, i.e. lasers. Using white light as illumination drastically reduces the effects of speckle 
while preserving the requirement of a coherence area that is at least as large as the field of view. 
In post-processing, sometimes subtracting the constant phase background (no sample QPI) helps. 
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 The above discussion makes it apparent that there is no perfect QPI method, i.e. there is 
no technique that performs optimally with respect to all figures of merit identified in the last 
section. The off-axis methods are fast as they are single shot, phase-shifting preserves the 
diffraction-limited transverse resolution without special measures, common-path methods are 
stable and white light illumination suffers less from speckle and, thus, is more spatially uniform. 
However, as we will see in the following sections, by combining these four approaches, the 
respective individual benefits may be added together.  
2.2 Diffraction Phase Microscopy 
Diffraction phase microscopy (DPM) is a full-field common path interferometry technique 
introduced by Popescu et al, in 2006 [8]. Figure 2.1 shows a typical DPM setup. The illumination 
source may be selected depending on the application at hand, and any source is sufficient as long 
as it is spatially coherent. Since DPM is usually implemented as an add-on to an inverted 
microscope, the only additional components that are necessary are a relay lens, a diffraction 
grating, and a 4-f spatial filtering setup. The image plane from the microscope is projected onto 
the diffraction grating via the relay lens. This generates several diffraction orders in the Fourier 
plane, which is projected onto the spatial filter via lens L1. Lens L2 is the inverse Fourier lens in 
the 4-f system and projects the interferogram onto a CCD.   
11 
 
 
Figure 2.1 DPM schematic (a) FC, fiber collimator; M, mirror; S, sample; O, objective lens; TL, tube 
lens; G, grating; SF, spatial filter; L1 and L2, lenses. (b) Close-up of a DPM image of 4 RBCs. 
The spatial filter allows passing the entire frequency content of the 1st diffraction order 
beam and blocks all the other orders. The 1st order is thus the imaging field and the 0th order 
plays the role of the reference field. The two beams traverse the same optical components, i.e. 
they propagate along a common optical path, thus significantly reducing the longitudinal phase 
noise. If the direction of the spatial modulation is chosen at an angle of 45o with respect to the x 
and y axes of the CCD, the total field at the CCD plane has the form 
  
 0 1( ) ( , )
0 1( , ) ( , )
 
 
i x y i x yU x y U e U x y e
  
.   (2.4) 
In Eq. 2.4, 0,1U  and 0,1  are the amplitudes and the phase, respectively, of the orders of 
diffraction 0, 1, while  represents the spatial frequency shift induced by the grating to the 0th 
order (i.e. the spatial frequency of the grating itself). Note that, as a consequence of the central 
ordinate theorem, the reference field is proportional to the spatial average of the microscope 
image field, 
    0 1
( , )
0
1
( , ) 
i i x yU e U x y e dxdy
A
 
,    (2.5) 
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where A is the total image area. The spatial average of an image field has been successfully used 
before as a stable reference for extracting spatially resolved phase information [9].  
The CCD recording may be written as 
  
2 2
( , ) ( , ) 2 ( , ) cos ( , )i r i rI x y U x y U U x y U qx x y    , (2.6) 
where q is the spatial frequency shift from the  diffraction grating. The interferogram is then 
spatially high-pass filtered to isolate the sinusoidal cross term. For phase objects, U1(x,y) is 
expected to have weak spatial dependence and thus the isolated term can be interpreted as the 
real part of a spatial complex analytic signal. The corresponding imaginary part can then be 
obtained via a Hilbert transform: 
  
2cos ( ', )
sin ( , )
'
qx x y
qx x y P
x x


   

, (2.7) 
where P is the principle value integral. The phase may then be recovered as 
      ( , ) arg cos ,sinx y qx qx qx         . (2.8) 
The diffraction limited resolution of the system can be preserved through proper selection of the 
spatial modulation, q. As with any other signal, this must meet the requirements of the Nyquist 
theorem, that it is twice the highest resolvable frequency. Since this value q is known from the 
period of the diffraction grating, it may simply be subtracted to retrieve φ(x,y). However since 
qx can be much higher than 2π, φ(x,y)+qx, can be highly wrapped. An unwrapping algorithm is 
thus applied prior to subtracting qx. Such algorithms search for 2π jumps in the phase and correct 
them. In this manner the phase can be recovered from a single CCD recording. 
Recently, DPM has been combined with epi-fluorescence microscopy in diffraction phase 
and fluorescence microscopy (DPF) to simultaneously image both the nanoscale structure and 
dynamics, and the specific functional information in live cells [24]. Further, confocal diffraction 
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phase microscopy (cDPM), has also been presented which provides quantitative phase 
measurements from localized sites on a sample with high sensitivity [25]. The ability of DPM to 
study live cells has been demonstrated on various systems such as whole blood measurements 
[26], imaging kidney cells in culture [24], Fresnel particle tracking [27], red blood cell 
mechanics [28], imaging of malaria-infected RBCs [29] etc. In Chapter 4 I describe the use of a 
DPM platform for quantitative cytometry of red blood cells. 
2.3 Spatial Light Interference Microscopy 
As discussed above, a large number of experimental setups have been developed for QPI 
however, the contrast in QPI images has always been limited by speckles resulting from the 
practice of using highly coherent light sources such as lasers. The spatial non-uniformity caused 
by speckles is due to random interference phenomena caused by the coherent superposition of 
various fields from the specimen and those scattered from optical surfaces, imperfections or dirt 
[30]. Since this superposition of fields is coherent only if the path length difference between the 
fields is less than the coherence length (lc) of the light, it follows that if broadband light with a 
shorter coherence length is used, the speckle will be reduced. Due to this, the image quality of 
laser based QPI methods has never reached the level of white light techniques (lc ~ 1 µm) such as 
phase contrast or DIC as discussed below.  
To address this issue I participated in the development of a new QPI method called 
Spatial Light Interference Microscopy (SLIM) [31, 32]. SLIM combines two classical ideas in 
optics and microscopy: Zernike’s phase contrast method [5] for using the intrinsic contrast of 
transparent samples and Gabor’s holography to quantitatively retrieve the phase information 
[33]. SLIM thus provides the spatial uniformity associated with white light methods and the 
stability associated with common path interferometry. In fact, as described in greater detail 
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, 
below, the spatial and temporal sensitivities of SLIM to optical path length changes have been 
measured to be 0.3 nm and 0.03 nm respectively. In addition, due to the short coherence length 
of the illumination, SLIM also provides excellent optical sectioning, enabling three-dimensional 
tomography [15].  
In the laser based methods the physical definition of the phase shifts that are measured is 
relatively straightforward since the light source is highly monochromatic. However, for 
broadband illumination the meaning of the phase that is measured must be considered carefully. 
It was recently shown by Wolf [34] that if a broadband field is spatially coherent, the phase 
information that is measured is that of a monochromatic field which oscillates at the average 
frequency of the broadband spectrum. This concept is the key to interpreting the phase measured 
by SLIM. In this section I will first discuss the physical principles behind broadband phase 
measurements using SLIM, then the experimental implementation and finally various 
applications. 
The idea that any arbitrary image may be described as an interference phenomenon was 
first proposed more than a century ago by Abbe in the context of microscopy: “The microscope 
image is the interference effect of a diffraction phenomenon” [1].  This idea served as the basis 
for both Zernike’s phase contrast [5] and is also the principle behind SLIM. The underlying 
concept here is that under spatially coherent illumination, the light passing through a sample may 
be decomposed into its spatial average (unscattered component) and its spatially varying 
(scattered component) as 
0 1
0 1
( ) ( ; )
0 1
( ; ) ( ) ( ; )
( ) ( ; )
i i
U U U
U e U e
   
  
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 
  r
r r
r
    (2.9) 
where r=(x, y). In the Fourier plane (back focal plane) of the objective lens these two 
components are spatially separated, with the unscattered light being focused on-axis as shown 
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Fig. 2.2. In the spatial Fourier transform of the field U, ( ; )U q  , it is apparent that average field 
U0 is proportional to the DC component ( ; )U 0 . This is equivalent to saying that if the 
coherence area of the illuminating field is larger than the field of view of the image, the average 
field may be written as 
    0
1
( , ) ( , )U U x y U x y dxdy
A
   .     (2.10) 
Thus the final image may be regarded as the interference between this DC component and the 
spatially varying component. Thus the final intensity that is measured may be written as: 
 
2 2
0 1 0 1( , ) ( , ) 2 ( , ) cos ( , )I x y U U x y U U x y x y    ,     (2.11) 
where Δϕ is the phase difference between the two components. Since for thin transparent 
samples this phase difference is extremely small and since the Taylor expansion of the cosine 
term around 0 is quadratic, i.e. 
2
cos( ) 1
2



   , the intensity distribution does not reveal 
much detail. Zernike realized that the spatial decomposition of the field in the Fourier plane 
allows one to modulate the phase and amplitude of the scattered and un-scattered components 
relative to each other. Thus he inserted a phase-shifting material in the back focal plane that adds 
a π/2 shift (k=1 in Fig. 2.2) to the un-scattered light relative to the scattered light, essentially 
converting the cosine to a sine which is rapidly varying around 0 ( sin( )    ). Thus Zernike 
coupled the phase information into the intensity distribution and invented phase contrast 
microscopy. Phase contrast (PC) has revolutionized live cell microscopy and is widely used 
today; however, the quantitative phase information is still lost in the final intensity measurement. 
SLIM extends Zernike’s idea to provide this quantitative information. 
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 As in PC microscopy, SLIM relies on the spatial decomposition of the image field into its 
scattered and un-scattered components and the concept of image formation as the interference 
between these two components. Thus in the space-frequency domain we may express the cross 
spectral density as [35, 36]:  
*
01 0 1( ; ) ( ) ( ; )W U U   r r       (2.12) 
where the * denotes complex conjugation and the angular brackets indicate an ensemble average. 
If the power spectrum 
2
0( ) ( )S U  has a mean frequency 0 , we may factorize the cross 
spectral density as 
0[ ( ; )]
01 0 01 0( ; ) ( ; )
i
W W e
          rr r  .    (2.13) 
From the Wiener–Kintchen  theorem [36], the temporal cross correlation function is related to 
the cross spectral density through a Fourier transform and can be expressed as 
          
0[ ( ; )]
01 01( ; ) ( ; )
i
e
        rr r
 ,
    (2.14) 
where 0 1( ) ( )    r r is the spatially varying phase difference. It is evident from Eq. 2.14 that 
the phase may be retrieved by measuring the intensity at various time delays,  . The retrieved 
phase is equivalent to that of monochromatic light at frequency 0 . This can be understood by 
calculating the auto-correlation function from the spectrum of the white-light source being used 
(Fig 2.2 c-d). It can be seen in the plot of the autocorrelation function in Fig. 2.2 d that the white 
light does indeed behave as a monochromatic field oscillating at a mean frequency of 0 . 
Evidently, the coherence length is less than 2μm, which as expected is significantly shorter 
compared to quasi-monochromatic light sources such as lasers and LEDs.  However, as can be 
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seen, within this coherence length there are several full cycle modulations, and in addition, the 
envelope is still flat near the central peak.   
 
Figure 2.2. Imaging as an interference effect. (a) A simple schematic of a microscope is shown where 
L1 is the objective lens which generates a Fourier transform of the image field at its back focal plane. The 
un-scattered component of the field is focused on-axis and may be modulated by the phase modulator 
(PM). The tube lens L2 performs an inverse Fourier transform, projecting the image plane onto a CCD for 
measurement. (b) Spectrum of the white light emitted by a halogen lamp source, with center wavelength 
of 531.9 nm. (c) Resampled spectrum with respect to frequency. (d) Autocorrelation function (solid line) 
and its envelope (dotted line). The four circles correspond to the phase shifts that are produced by the PM 
in SLIM. 
When the delay between U0 and U1 is varied, the interference is obtained simultaneously 
at each pixel of the CCD; thus, the CCD may be considered as an array of interferometers. The 
average field, U0, is constant over the field of view and serves as a common reference for each 
pixel. It is also important to note that U0 and U1 share a common optical path, thus minimizing 
any noise in the phase measurement due to vibrations. The intensity at the image plane may be 
expressed as a function of the time delay as:
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 0 1 01 0( ; ) ( ) 2 ( ; ) cos ( )I I I        r r r r ,    (2.15) 
 In SLIM, to quantitatively retrieve the phase the time delay is varied to get phase delays 
of –π, π/2, 0 and π/2 ( 0 / 2k k   , k= 0, 1, 2, 3) as illustrated in Fig. 2.2d. An intensity map is 
recorded at each delay and may be combined as: 
 ( ;0) ( ; ) 2 (0) ( ) cos ( )I I           r r r     (2.16) 
          ( ; ) ( ; ) 2 sin ( )
2 2 2 2
I I
   

    
          
    
r r r .    (2.17) 
For time delays around 0 that are comparable to the optical period,  can be assumed to vary 
slowly at each point as shown in Fig. 2.2d. Thus for cases where the relationship 
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holds true the spatially varying phase component may be 
expressed as: 
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Letting 1 0( ) ( ) / ( )U U r r r , the phase associated with the image field is determined as: 
( )sin( ( ))
( ) arg
1 ( )cos( ( ))
 

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.     (2.19) 
Thus by measuring 4 intensity maps the quantitative phase map may be uniquely determined. 
Next we will discuss the experimental implementation of SLIM and its performance. 
19 
 
A schematic of the SLIM setup is shown in Fig. 2.3a. SLIM is designed as an add-on module to a 
commercial phase contrast microscope (more details about the SLIM design and peripheral 
accessories can be found in Appendix B).  In order to match the illumination ring with the 
aperture of the spatial light modulator (SLM), the intermediate image is relayed by a 4f system 
(L1 and L2). The polarizer P ensures the SLM is operating in a phase modulation only mode. 
The lenses L3 and L4 form another 4f system. The SLM is placed in the Fourier plane of this 
system which is conjugate to the back focal plane of the objective which contains the phase 
contrast ring. The active pattern on the SLM is modulated to precisely match the size and 
position of the phase contrast ring such that the phase delay between the scattered and 
unscattered components may be controlled as discussed above. 
To determine the relationship between the 8-bit VGA signal that is sent to the SLM and 
the imparted phase delay, it is first necessary to calibrate the liquid crystal array as follows. The 
SLM is first placed between two polarizers which are adjusted to be 45o to the SLM axis such 
that it operates in amplitude modulation mode. Once in this configuration the 8-bit grayscale 
signal sent to the SLM is modulated from a value of 0 to 127 (the response from 128 to 255 is 
symmetric). The intensity reflected by the SLM is then plotted vs. the grayscale value as shown 
in Fig. 2.3b. The phase response is calculated from the amplitude response via a Hilbert 
transform (Fig. 2.3c).  From this phase response the 3 phase shifts necessary for quantitative 
phase reconstruction may be obtained as shown in Fig. 2.3d. Finally a quantitative phase map 
image may be determined as described above.  
Figure 2.3e shows a quantitative phase measurement of a cultured hippocampal neuron; 
the color indicates the optical path in nanometers at each pixel. The measured phase can be 
approximated as 
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where k0=2/, n(x,y,z)-n0 is the local refractive index contrast between the cell and the 
surrounding culture medium,  
( , )
0
0
1
( , ) ( , , )
( , )
h x y
n x y n x y z n dz
h x y
   , the axially-averaged 
refractive index contrast, h(x,y) the local thickness of the cell, and  the mean wavelength of the 
illumination light. The typical irradiance at the sample plane is ~1 nW/ m2. The exposure time 
is typically 1-50 ms, which is 6-7 orders of magnitude less than that of confocal microscopy [37], 
and thus there is very limited damage due to phototoxic effects. In the original SLIM system the 
phase modulator has a maximum refresh rate of 60 Hz and the camera has a maximum 
acquisition rate of 11 Hz; due to this the maximum rate for SLIM imaging was 2.7 Hz. Of course 
this is only a practical limitation as both faster phase modulators and cameras are available 
commercially. 
21 
 
 
Figure 2.3 Experimental setup. (a) The SLIM module is attached to a commercial phase contrast 
microscope (AxioObserver Z1, Zeiss). The first 4-f system (lenses L1 and L2) expands the field of view 
to maintain the resolution of the microscope. The polarizer, P, is used to align the polarization of the field 
with the slow axis of the Spatial Light Modulator (SLM). Lens L3 projects the back focal plane of the 
objective, containing the phase ring onto the SLM which is used to impart phase shifts of 0, π/2, π and 
3π/2 to the un-scattered light relative to the scattered light as shown in the inset. Lens L4 then projects the 
image plane onto the CCD for measurement. (b) Intensity modulation obtained by displaying different 
grayscale values on the SLM. (c) Phase modulation vs. grayscale value obtained by a Hilbert transform on 
the data in b. (d) The 4 phase rings and their corresponding images recorded by a CCD. (e) Reconstructed 
quantitative phase image of a hippocampal neuron, the color bar indicates the optical path length in 
nanometers. 
To quantify the spatiotemporal sensitivity of SLIM a series of 256 images with a field of 
view of 10 x 10 µm2 were acquired with no sample in place. Figure 2.4a shows the spatial and 
temporal histograms associated with this data. The spatial and temporal sensitivities were 
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measured to be 0.28 nm and 0.029 nm respectively. Figure 2.4b-c compares SLIM images with 
those acquired using  a diffraction phase microscope (DPM) [8] that was interfaced with the 
same commercial microscope. The advantages provided by the broadband illumination are clear 
as the SLIM background image has no structure or speckle as compared to those acquired by 
DPM.  
 
Figure 2.4. SLIM sensitivity. (a) Spatial and temporal optical path length noise level, solid lines indicate 
Gaussian fits.  (b) Topographic noise in SLIM. (c) Topographic noise in DPM a laser based method. The 
color bar is in nanometers. 
2.4 Discussion 
I anticipate that QPI technologies will become a dominant field in biomedical optics in 
the years to come. Clearly, the methods have come a long way and have exciting potential for 
enabling new biological studies with the required resolution, repeatability, and compatibility 
with existing techniques. QPI provides sensitivity to spatial and temporal pathlength changes 
down to the nanoscale. This has been exploited, for example, in studies of red blood cell 
fluctuations and topography of nanostructures. However this sensitivity should not be referred to 
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as axial resolution. Nanometer resolution or resolving power would describe the ability of QPI to 
resolve two objects separated axially by 1 nm. Of course, this is impossible, due to the 
uncertainty principle.  
 As discussed in Chapter 3, the phase information allows us to interpret the data as an 
image or scattering map, depending on whether we are interested in keeping the spatial 
information, and average the angular scattering information or vice versa. Most importantly, the 
quantitative phase image represents a density map, whose behavior in space and time can be 
analyzed and understood quantitatively using physical models. Whether a morphological feature 
can report on tissue cancer or a dynamic behavior teaches us about cell transport, QPI is a new 
powerful approach to biomedicine. In Chapter 3 I discuss how QPI data can be analyzed and 
interpreted to provide such biological insights. In the years to come, I believe that QPI can 
become a significant tool in the current transition of biology from empirical to quantitative 
science.  
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CHAPTER 3. ANALYSIS OF QUANTITATIVE PHASE DATA * 
As in all QPI techniques the phase information measured by SLIM and DPM is 
proportional to the refractive index times the thickness of the sample (see Eq. 2.20). Due to the 
coupling of these two variables the natural choices for applying a QPI instrument are in 
situations where either the refractive index (topography) or the thickness (refractometry) is 
known [14]. When these parameters are measured dynamically, they can be used to measure 
membrane or density fluctuations, providing mechanical information on cellular structures [38]. 
Moreover, it was realized soon after the conception of quantitative phase microscopy, that the 
integrated phase shift through a cell is proportional to its dry mass (non-aqueous content) [39, 
40], which enables studying cell mass growth [13, 41] and mass transport [38, 42] in living cells. 
Furthermore, when the low-coherence illumination is combined with a high numerical aperture, 
objective SLIM provides excellent depth sectioning. When this capability is combined with a 
linear forward model of the instrument, it can be used to perform three-dimensional tomography 
on living cells [15] with sub-micron resolution.  Also, QPI data may be used to generated highly 
sensitive scattering measurements through a simple Fourier transform [43-47]. Thus the current 
major applications of SLIM may be broken down into five basic categories: refractometry, 
topography, dry mass measurement, tomography and scattering. In addition to basic science 
applications, SLIM has also been applied to clinical applications such as blood screening [48] 
and cancer diagnosis [49].  
Since SLIM is coupled to a commercial phase contrast microscope that is equipped with 
complete environmental control (heating, CO2, humidity), it is possible to perform long term live 
cell imaging. In fact with SLIM measurements of up to a week have been performed [13]. Due to 
                                                            
* Portions of this chapter are reproduced from a review article: M. Mir, B. Bhaduri, R. Wang, R. Zhu and G. 
Popescu, “Quantitative Phase Imaging”, Progress in Optics, Chennai, B.V.: (2012), pp. 133-217.  This material is 
reproduced with the permission of the publisher and is available using the ISBN: 978-0-444-59422-8. 
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the coupling with the commercial microscope, it is also possible to utilize all other commonly 
used modalities such as fluorescence simultaneously. Fluorescence imaging can be used to add 
specificity to SLIM measurements such as for identifying the stage of a cell cycle or the identity 
of an observed structure. Furthermore, since it is possible to resolve sub-cellular structure with 
high resolution, the inter- and intra- cellular transport of dry mass may also be quantified. Using 
mosaic style imaging, it is also possible to image entire slides with sub-micron resolution 
imaging by tiling and stitching adjacent fields of view. Thus SLIM may be used to study 
phenomena on time scales ranging from milliseconds to days and spatial scales ranging from 
sub-micron to millimeters. In my work I have leveraged all the capabilities discussed above. In 
the chapter I will describe in greater detail the analysis methods that I have used to interpret QPI 
data and provide physical meaning.  
3.1 Topography and Refractometry 
To assess the accuracy of topographic SLIM measurements, an amorphous carbon film 
(of known refractive index) was imaged using both SLIM and an atomic force microscope as 
shown in Fig 3.1. It can be seen that the two measurements agree within a fraction of a 
nanometer (Fig. 3.1a). It is important to note that both SLIM and AFM are characterized by 
smaller errors than indicated by the widths of the histogram modes, which reflect irregularities in 
surface profile due to errors in the fabrication process. Unlike AFM, SLIM is non-contact and 
parallel and more than 3 orders of magnitude faster. AFM can measure a 10 x 10 µm2 field of 
view in 21 minutes whereas SLIM can optically measure a 75 x 100 µm2 area in 0.5 seconds. Of 
course, unlike AFM, SLIM provides nanoscale accuracy in topographic measurements but still 
has the diffraction limited transverse resolution associated with the optical microscope. 
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Figure 3.1. Comparison between SLIM and AFM. (a) Topographical histograms for SLIM and AFM. (b) 
SLIM image of an amorphous carbon film. (c) AFM image of the same sample. 
Having established the nano-scale sensitivity and accuracy of SLIM, its topographic 
capabilities were further tested through measurements on graphene flakes [14] where it is 
necessary to resolve single atomic layers. Graphene is a two-dimensional lattice of hexagonally 
arranged and sp2-bonded carbon atoms. The graphene sample was obtained by mechanically 
exfoliating a natural graphite crystal using adhesive which was then deposited on a glass slide. 
This process results in both single-layer and multi-layer flakes being deposited on the slide with 
later dimensions on the order of tens of microns. Figure 3.2a shows the SLIM image of such a 
graphene flake. It can be qualitatively deduced from this image that the background noise is 
below the signal from the sample. To perform topographic measurements, the height at each 
pixel is calculated using Eq. 2.20 and inputting the known refractive index of graphite, n=2.6. 
Figure 3.2c shows the histograms of the height information. It can be seen in the overall 
histogram that there are local maxima in the distribution at heights of 0 nm (background), 0.55 
nm, 1.1 nm and 1.6 nm, indicating that the sample has a staircase profile in increments of 0.55 
nm. These values are comparable to the reported thickness of individual atomic layers of 
graphene measured using AFM in air (~ 1nm) or with a scanning tunneling microscope (STM, 
27 
 
0.4 nm) in ultra-high vacuum. The difference between the AFM and STM measurements is likely 
due to the presence of ambient species (nitrogen, oxygen, water, organic molecules) on the 
graphene sheet. From these results it can be concluded that SLIM is capable of measuring single 
atomic layers, with topographic accuracy comparable to AFM with a much faster acquisition 
time and in a non-contact manner. 
 
Figure 3.2. Topography and Refractometry (a) SLIM image of a graphene flake. (b) Topographic 
histograms of the regions indicated in (a). (c) Tube structure with refractive index and thickness of layers 
shown. (d) Histogram of the refractive index contrast, n− 1, of the selected area in the inset. Inset, 
distribution of refractive index contrast, n− 1. 
The refractometry capabilities of SLIM were demonstrated through measurements on 
semi-conductor nanotubes (SNT) [14]. SNTs are an emerging nanotechnology building block 
that are formed by the self-rolling of residually strained thin films that are grown epitaxially and 
defined lithographically. Since the nanotubes have a known cylindrical geometry, it is possible to 
deduce the thickness of the tubes from the projected width which is directly measurable in the 
image. Assuming that the thickness and the width are equal, it is possible to extract the average 
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refractive index of the tube using Eq. 2.20. The expected value of the refracted index was 
calculated by averaging the refractive indices of the layered structure shown in Fig. 3.2c. The 
measured values shown in Fig. 3.2c agree very well with the expected values ( nmeasured=0.093, 
 nexpected=0.087). The fluctuations observed in the refractive index are most likely due to 
physical inhomogeneities in the tube itself. Thus SLIM provides a way to do high throughput 
refractometry on nanofabricated structures. A similar procedure was also demonstrated for 
measuring the refractive index of neural processes which are also cylindrical [14]. 
3.2 Dry Mass Measurements 
Along with differentiation and morphogenesis, cell growth is one of the fundamental processes 
of developmental biology [50]. Due to its fundamental importance and the practical difficulties 
involved measuring cell growth, the question of how cells regulate and coordinate their growth 
has been described as “one of the last big unsolved problems in cell biology”[51]. The reason 
that this measurement has been elusive despite decades of effort is simply that cells are small, 
weighing in on the order of pictograms, and they only double their size during their lifecycle. For 
this reason, the accuracy required to answer basic questions such as whether the growth is 
exponential or linear is on the order of femtograms [52]. 
 The traditional approach for measuring cell growth is to use a Coulter counter to measure 
the volume distribution of a large population of cells and perform careful statistical analysis to 
deduce the behavior of single cells [52]. This type of analysis does not provide single cell 
information and does not permit cell cycle studies without synchronizing the population using 
techniques that may alter the behavior. For cells with regular shapes such as E. coli and other 
relatively simple cells, traditional microscopy techniques have also been used to study size 
parameters such as projected area and length in great detail [53]. However, this approach 
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assumes that the cell density remains constant, such that the size is analogous to the mass which 
is not always true as the size may change disproportionally to mass due to osmotic responses 
[41]. More recently several novel microelectromechanical (MEMS) devices have been developed 
to essentially weigh single cells by measuring the shift in the resonant frequency of micro-scale 
structures as cells interact with them [54-56]. Although, these devices are impressive in terms of 
throughput, they are limited to either measuring a large number of cells without the ability for 
single cell analysis or measuring only one cell at a time. It is well recognized that the ideal 
approach should have the capability to measure single cells and their progeny, be non-invasive 
and provide information at both the cell and population level with the required sensitivity.  
 Quantitative phase measurements are thus a natural choice to study cell growth. In fact it 
was realized in the 1950s, soon after the invention of phase contrast microscopy, that the 
integrated phase shift through a cell is linearly proportional to its dry mass [39, 40]. This may be 
understood by expressing the refractive index of a cell as: 
0( , ) ( , )cn x y n C x y           (3.1) 
where β (ml/g) is known as the refractive increment, which relates the change in concentration of 
protein, C (g/ml),  to the change in refractive index. Here n0 is the refractive index of 
surrounding cytoplasm. According to intuition an uncertainty arises in determining the refractive 
increment method when considering the heterogeneous and complex intracellular environment. 
However, measurements indicate that this value varies less than 5% across a wide range of 
common biological molecules [39, 40]. It was also recently shown using Fourier phase 
microscopy [9] that the surface integral of the phase map is invariant to small osmotic changes, 
which establishes the validity of using QPI techniques for cell dry mass measurements. Using 
Eq. 3.1 the dry mass surface density at each pixel of a quantitative phase image is calculated as: 
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This method of measuring cellular dry mass has been used by several groups over the past half 
century [57-59]; however, until the development of SLIM, QPI instruments have generally been 
limited in their sensitivity and stability as described in detail earlier. Specifically, SLIM’s path 
length sensitivities of 0.3 nm spatially and 0.03 nm temporally translate to temporal dry mass 
sensitivities of 1.5 fg/µm2 and 0.15 fg/µm2 respectively. Thus SLIM finally enabled the optical 
measurement of cell growth with the required sensitivity. I recently demonstrated these 
capabilities through measurements on both Escherichia coli (E. coli) cells and a mammalian 
human osteosarcoma cell line [13] as discussed in Chapter 4. Furthermore this idea was 
leveraged to create a cancer cell proliferation assay as described in Chapter 5 and to study neural 
network formation as described in Chapter 6.  
3.3 Fourier Transform Light Scattering (FTLS) 
Perhaps one of the most striking features of QPI is that it can generate light scattering data with 
extreme sensitivity. This happens because full knowledge of the complex (i.e., amplitude and 
phase) field at a given plane (the image plane) allows us to infer the field distribution at any 
other plane, including in the far zone. In other words, the image and scattering fields are simply 
Fourier transforms of each other; this relationship does not hold in intensity. This approach, 
called Fourier transform light scattering (FTLS) [43-47] is much more sensitive than common, 
goniometer-based angular scattering because the measurement takes place at the image plane, 
where the optical field is most uniform. As a result, FTLS can render with ease scattering 
properties of minute subcellular structures, which is an unprecedented capability. 
When measuring mostly transparent, optically thin samples, we can assume that the 
amplitude of the optical field is left unperturbed and that only the phase measured by SLIM is 
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altered by the sample. In this case, SLIM provides a measure of the complex optical field, 
( , )( , ) ( , ) i tU t U t e  rr r , at the sample plane. This field may then be numerically propagated to the 
far-field or scattering plane by simply calculating its spatial Fourier transform as 
2( ) ( ) iqU U e d  
r
q r r , where q is the scattering wave vector. The modulus square of this 
function,
2
( ) ( )P Uq q , is related to the spatial auto-correlation of the measured complex field 
through a Fourier transform, 2 2( ) ( ') ( ') 'iqP e d U U d   
r
q q r r r r , and thus describes the spatial 
correlation of the scattering particles in the sample.  Since the signal is measured and 
reconstructed in the image plane, rather than in the far field as in traditional scattering 
experiments, all the scattering angles that are allowed by the numerical aperture of the 
microscope objective are measured simultaneously. This greatly enhances the sensitivity to 
scattering compared to the traditional approach of goniometric measurements. 
Fourier transform light scattering has already been used for the purposes of studying 
scattering from entire organs, cancer diagnosis and prognosis and scattering from single cells 
[43-47]. In Chapter 7. I show how FTLS can be used to measure spatial organization in 
developing neural networks. 
3.4 Dispersion Analysis: Membrane Fluctuations and Mass Transport 
In addition to simply growing, single cells must also organize and transport mass in forms 
ranging from single molecules to large complexes in order to achieve their functions. Cells rely 
on both passive (diffusive) and active (directed) transport to accomplish this task. Active 
transport, typically over long spatial, scales is accomplished using molecular motors, which have 
been tracked and measured previously using single molecule fluorescence techniques (e.g., see 
[60]). Establishing a more complete view of the spatial and temporal distribution of mass 
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, 
transport in living cells remains a challenging problem; addressing this problem requires 
measuring the microscopic spatiotemporal heterogeneity inside the cells. This has been 
addressed in the past by both active and passive particle tracking [61, 62]. Recently it was shown 
that this may also be accomplished using QPI techniques by measurements taken on living cells 
using SLIM [38, 42]. 
 If measured over time the changes in path-length that are measured by SLIM can be 
expressed to the first order as: 
                     
,
, , , ,
, ,
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   
   
r r r
r r r r r r
r r r r
  (3.3) 
where s(r,t) is the optical path length , r=(x,y), h is the local thickness and n is the local 
refractive index contrast. As can be seen in Eq. 2.15 the fluctuations in the path length contain 
information about out-of-plane fluctuations in the thickness and in plane fluctuations in the 
refractive index. The out-of-plane fluctuations have previously been extensively measured in the 
context of red blood cell membrane fluctuations using QPI [28, 63], which typically occur at fast 
temporal frequencies. The in-plane fluctuations correspond to intracellular mass transport. 
Separating the membrane fluctuations and mass transport components from s can be performed 
by ensuring that the image acquisition rate is lower than the decay rates associated with the 
bending and tension modes of membrane fluctuations.  
 As discussed in the section on growth above, the SLIM image may be regarded as a 2D 
dry mass density map and thus the changes in this map satisfy an advection-diffusion equation 
that includes contributions from both directed and diffusive transport [64]:  
  
2 ( , ) ( , ) ( , ) 0D t t t
t
  

    

r v r r .     (3.4) 
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where D is the diffusion coefficient, v is the advection velocity and   is the dry mass density. 
The spatiotemporal autocorrelation function of the density can be calculated as: 
    , '
( ', ) ( , ) ( ', )
t
g t t     
r
r r r r  .       (3.5) 
Taking a spatial Fourier transform of Eq. 3.5 the temporal autocorrelation may be expressed for 
each spatial mode, q, as: 
           
2
( , ) iq Dqg q e     v           (3.6) 
thus relating the measuring temporal autocorrelation function to the diffusion coefficient and 
velocity of matter. This is the same autocorrelation function that can be measured in dynamic 
light scattering at a fixed angle. In SLIM the entire forward scattering half space is measured 
simultaneously, limited only by the numerical aperture of the objective. Thus SLIM essentially 
functions as a highly sensitive light scattering measurement instrument.  
 The measured data is averaged over a range of advection velocities so Eq. 3.6 must be 
averaged as: 
   
2 2 2
0( , )
iq Dq Dq iqg q e e P e d         
v v
v
v v v   .                          (3.7) 
 
Since the maximum speeds of molecular motors are approximately 0.8 µm/s and since there is 
transport over a large range of directions, the average velocity that is measured must be 
significantly lower than this value. Hence, it was proposed that the probability distribution, P, of 
local advection velocities is a Lorentzian of width v and that the mean advection velocity 
averaged over the scattering value is much smaller, 0v v  . Thus, Eq. 3.7 may be evaluated as 
   
2
( , )
i q v Dqg q e e
       0q v  ,                                         (3.8) 
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The mean velocity produces a frequency modulation ( )  0q v q  to the temporal 
autocorrelation, which decays exponentially at a rate 
     
2( )q vq Dq    .                   (3.9) 
Equation 3.9 is the dispersion relationship which gives the technique its name of Dispersion 
Phase Spectroscopy (DPS). Thus from a 3D (x,y,t) SLIM dataset, the dispersion relationship 
( , )x yq q may be calculated by first performing a spatial Fourier transform of each frame and 
then by calculating the temporal bandwidth at each spatial frequency by performing a temporal 
Fourier transform. The radial function, ( )q , where 
2 2
x yq q q  , is obtained by an azimuthal 
average of the data. 
 To verify this approach SLIM was used to image the Brownian motion of 1 µm 
polystyrene sphere in a 99% glycerol solution (Fig. 3.3 a). Images were acquired for 10 minutes 
at a rate of 1 Hz. The diffusion coefficient was first determined by conventional particle tracking 
(Fig. 3.3 b) and then using DPS (Fig. 3.3 c-d) with excellent agreement. The DPS approach is 
significantly faster as it does not require tracking individual particles and also applies to particles 
which are smaller than the diffraction spot of the microscopy. In addition, in the case of living 
cells where there are usually no intrinsic particles available for tracking, DPS provides a simpler 
alternative than adding extrinsic particles to the cells. Using DPS several cell types have been 
measured including neurons, and glial and microglial cells [42, 64]. Figure 3.3 e-f shows such a 
measurement on a microglial cell. The dispersion curve shown in Fig. 3.3 f is associated with a 
narrow strip whose long axis is oriented radially with respect to the cell’s nucleus (white box). It 
can be seen that the transport is diffusive below spatial scales of 2 µm and directed above. The 
findings suggest that both diffusion and the advection velocities are inhomogeneous and 
anisotropic.  
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 DPS thus provides the ability to quantify mass transport in continuous and transparent 
systems in a label-free manner. Experiments on live cells using this method have shown that the 
transport is diffusive at scales below a micron and deterministic at larger scales as expected from 
current knowledge about biology. Since DPS uses SLIM to acquire the phase maps, the total dry 
mass of the cell and other information such as fluorescence may be acquired simultaneously.  
 
Figure 3.3 Dispersion Phase Spectroscopy (a) Quantitative phase image of 1μm polystyrene beads in 
glycerol. Colorbar indicates pathlength in nm. (b) Mean squared displacements (MSD) obtained by 
tracking individual beads in a. The inset illustrates the trajectory of a single bead. (c) Decay rate vs. 
spatial mode, Γ(q), associated with the beads in a. The dash ring indicates the maximum q values allowed 
by the resolution limit of the microscope. (d) Azimuthal average of data in (c) to yield Γ(q). The fit with 
the quadratic function yields the value of the diffusion coefficient as indicated. (e) SLIM image of a 
microglial cell. (f) Dispersion curves, Γ(q), associated with the white box regions in (e). The 
corresponding fits and resulting D and Δv values are indicated. The green and red lines indicate directed 
motion and diffusion, respectively, with the results of the fit as indicated in the legend.  
3.5 Spatial Light Interference Tomography (SLIT) 
In addition to rendering high resolution 2D quantitative phase maps, SLIM has the ability to 
provide optical sectioning, providing a pathway to 3D tomographic measurements [15]. This 
sectioning capability is inherent in SLIM due to main factors. First, there is coherence gating due 
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to the short coherence length (~ 1.2 µm) of the white-light illumination. If the coherence length 
is shorter that the optical path difference between two scattering particles, the interference term 
between the scattered and unscattered light disappears, thus providing sectioning. Second, using 
a high numerical aperture objective in conjunction with SLIM provides depth-of-focus gating. 
Since in SLIM the two interfering fields are inherently overlapped, so are the two optical gates.  
 Recently it was shown that it is possible to render three-dimensional refractive index 
maps from SLIM 3D images using a linear forward model based on the first order Born 
approximation. This technique has appropriately been dubbed Spatial Light Interference 
Tomography (SLIT) [15]. The scattering model was formulated by first considering a plane wave 
incident on a specimen which becomes a source for a secondary field. That is, the fields that are 
scattered by every point in the sample propagate as spherical waves and interfere with the un-
scattered plane wave. The microscope objective may simply be considered as a band-pass filter 
in the wave vector (k) space. Thus at each of the optical frequencies the 3D field distribution 
may be measured by SLIM via depth scanning; the measured field may considered as a 
convolution between the susceptibility of the specimen   and the point spread function, P,  of 
the microscope 
                     
3( ) ( ') ( ') 'U P d r r r r r ,                             (3.10) 
where
2( ) ( ) 1n  r r , the spatial component of the susceptibility is the quantity of interest. In 
the frequency domain Eq. 3.10 may be written as 
                             ( ) ( ) ( )U Pq q q .                                         (3.11) 
Thus in the frequency domain, the susceptibility may be simply obtained as the ratio of the 
measured field and the PSF. For SLIT the point spread function was determined experimentally 
by imaging microspheres with diameters less than a third of the diffraction spot. Using the 
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measured PSF it is then possible to perform 3D tomography on various transparent samples, 
rendering inhomogeneous refractive index maps. Figure 3.4 (from [15]) provides an example of 
SLIT measurements on a living neuron which show excellent agreement with previous results. 
Figure 3.4 c-d provides a comparison of the 3D rendering provided by SLIM and a fluorescence 
confocal microscope. It can be seen that qualitatively the morphology of the two images is very 
close. The higher resolution provided by the confocal microscope is due to the fact that a higher 
NA objective was used for those measurements; furthermore, for confocal microscopy the 
neuron had to be stained and fixed. In contrast, SLIT is label-free and can non-invasively image 
living cells. In the next section I will discuss how super-resolution 3D tomography can be 
accomplished using sparse deconvolution algorithms with SLIT. 
 
Figure 3.4. Tomography capability. (a)-(b) Refractive index distribution through a live neuron at 
position z = 0.4 µm (a) and 6.0 µm (b). The soma and nucleolus (arrow) are clearly visible. Scale bars, 10 
µm. (c) 3D rendering of the same cell. The field of view is 100 µm × 75 µm × 14 µm and NA = 0.75. (d) 
confocal microscopy of a stained neuron with same field of view and NA = 1.2. Neurons were labeled 
with anti-polysialic acid IgG #735. The 3D rendering in (c) and (d) was done by ImageJ 3D viewer. 
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3.6 Visualizing Subcellular Structure using Deconvolved Spatial Light Interference 
Tomography (dSLIT) * 
Over the past two decades, fluorescence microscopy has enabled a number of super-
resolution technologies, including Stimulated Emission Depletion microscopy (STED) [65], 
Stochastic Optical Reconstruction Microscopy (STORM) [66], (Fluorescence) Photo-Activated 
Localization Microscopy, (f)PALM [67, 68], Spatially Structured Illumination Microscopy 
(SSIM) [69], etc., collectively referred to as far-field nanoscopy techniques (for a review, see 
Ref. [70]). Impressively, these methods provide a transverse resolution of 20-30 nm. Abbe’s 
resolution limit is overcome by taking advantage of the nonlinear properties (e.g., saturation, 
switching) of the engineered fluorophores. Since these methods require scanning or many frames 
to reconstruct the final image, they are often limited by severe tradeoffs between acquisition time 
and field of view. More importantly, the nonlinear light-specimen interactions require a high 
level of illumination intensity, which in turn adds limitations due to photodamage and 
photobleaching.  
In recent years it has become increasingly clear that to truly understand cellular function, 
it is necessary to image with high resolution in three dimensions; many of the fluorescence 
techniques mentioned above have also been adapted to work in 3D. Confocal microscopy is the 
most commonly used technique for 3D imaging and provides an axial resolution of 
approximately 500 nm [37]. 4Pi microscopy yields an axial resolution of 90 nm [71], while, 
more recently, 3D-STORM provides 50 – 60 nm resolution [72]. Another approach for 3D re-
construction is deconvolution microscopy, in which the blurring of the fluorescence image due to 
                                                            
* This section appeared in its entirety (with some modifications) in M. Mir, S.D. Babacan, M. Bednarz, M. N. Do, I. 
Golding and G. Popescu, Visualizing Escherichia coli Sub-Cellular Structure using Sparse Deconvolution Spatial 
Light Interference Tomography, PLoS One, 7, (6), e38916 (2012).  This material is reproduced with the permission 
of the publisher. 
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diffraction is treated as a linear problem and reversed numerically. Note that, of course, only the 
amplitude (intensity) of the field is measured in all these methods. 
As discussed in Section 3.5, if instead of just measuring intensity, the complex field (i.e., 
phase and amplitude) is measured, the 3D reconstruction of the specimen structure can be 
obtained without the need for exogenous contrast agents. In addition to SLIT [15], advances in 
QPI methods have enabled three-dimensional optical tomography of transparent biological 
samples using Radon transform based algorithms that were originally developed for X-ray 
computed imaging [73-75]. QPI based projection tomography has also been demonstrated on live 
cells with several approaches demonstrating high resolution [76-81].  
Despite the advantages provided by QPI methods, their resolution is still diffraction 
limited [82]. Such degradations are common to all optical instruments and may be reduced to an 
extent through post-processing methods such as deconvolution. Deconvolution works by 
inverting the optical transfer function of the instrument and has been widely used in intensity 
based techniques [83, 84]. However, such methods have not been investigated thoroughly on 
complex fields measured by QPI instruments. Previous work [85] suggests that the noise-
amplification that is commonly encountered when applying deconvolution to intensity images is 
not significant when they are applied to complex field measurements. The high SNR phase 
measurements obtained by SLIM provide a far more accurate modeling of the convolution with 
the PSF of the optical system in the complex fields, compared to the approximate convolution 
model typically used for intensity based methods. So far two novel deconvolution methods have 
been developed for SLIM. First, a non-linear method [86] was developed that estimates the 
unknown amplitude and phase through a combination of variable projection and quadratic 
regularization on the phase. The second method, called dSLIM [87], is based on modeling the 
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image using sparsity principles. This type of modeling is very effective in capturing the fine-
scale structural information that is lost due to the instruments optical transfer function. It was 
shown that dSLIM provides a resolution increase by a factor of 2.3, enabling super-resolution 
imaging with SLIM. Here I present sparse deconvolution spatial light interference tomography 
(dSLIT). This new method provides super-resolution in 3D and allows us to study the fine scale 
sub-cellular structure present in E. coli. 
The idea that the sub-cellular environment of E. coli cells is simply an amorphous mix 
have been proven to be incorrect, mostly due to the availability of high-resolution fluorescence 
methods. Numerous structures and distinct localizations of proteins have been studied such as the 
MinCD complex [88, 89], FtsZ [90-92] and MreB [89]. Furthermore, localization and structure 
has also been observed in the deposition of Lipopolysaccharides [93]. Interestingly many of 
these proteins have been found to lie in a helical or coil formation. The nature of these helices 
and coils is still under active investigation and many important questions remain to be answered. 
However, studying these sub-cellular structures using fluorescence requires specialized strains 
and probes, which inhibit the observation of these structures in wild-type strains in a non-
invasive manner. In this section, I show that dSLIT can be used to render high-resolution images 
of the three-dimensional subcellular structure in E. coli cells. I found that dSLIT can characterize 
the behavior and interactions of these structures without using fluorescent labels. 
The following notation is used in this section: Bold letters h and H denote vectors and 
matrices, respectively, with transposes hT and HT. The spatial coordinates within an image are 
denoted by (x, y, z), operator ∗ denotes convolution, and i is equal to √−1. Finally,   is used to 
denote a set created with its argument.  
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As described in reference [32], under the first order Born approximation, the 3D complex 
field distribution measured by SLIM, U(r) = |U(r)|exp[iΦ(r)], can be expressed as a convolution 
between the susceptibility of the object, 
2( ) ( ) 1n  r r  (where n is the refractive index), and 
the point spread function of the microscope, h(r). Essentially, the imaging system acts as a 
bandpass filter in the spatial frequency domain. Thus the measured field can be written as
  3  ( ) ( ') '
V
U h d r r r r r , where U  is the complex analytic signal associated with the real 
field. The PSF, h, can be determined within the Born approximation by considering the 
contribution of all the optical components in the system. However, this calculation only provides 
the response of an idealized system. Thus, I measured the PSF experimentally by imaging 
microspheres with diameters less than the size of the diffraction spot such that they essentially 
behave as point scatterers.  Therefore, for the purposes of the deconvolution procedure presented 
here we may model the measured field, U , as  
       
        *  ( )  U h  r r r r ,     (3.12) 
where  (r) is the additive signal-independent noise. Generally, both the magnitude and the 
phase of the image function are affected by the PSF and the noise. However, the degradation in 
the magnitude field is much smaller compared to the degradation in the phase [85]. Moreover, 
most of the useful biological information is contained in the phase image, and the magnitude 
image is not of much interest. Therefore, it is reasonable to assume that the magnitude of the 
image is constant and passes through the instrument without degradation, i.e., 
( ) ( )U U const r r . This assumption allows us to remove the magnitude component, and 
write the deconvolution problem solely in terms of the phase Φ (r) as  
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(3.13) 
where σ2 is the noise variance, and R(·) is the regularization functional used to enforce certain 
image properties during deconvolution. Let us now denote by g(r) the field exp ( )i  r  acquired 
by the microscope, and by f (r) the unknown field  exp ( )i r  we are trying to recover. These 
fields can be represented as vectors g and f, respectively, by stacking the images as single 
columns with N pixels. Using this representation, the image formation in Eq. 3.10 can be written 
in matrix-vector form as 
  g Hf + ,         (3.14) 
where H is the convolution matrix corresponding to the PSF h(r). Similarly, the deconvolution 
problem in Eq. 3.12 can be expressed as 
2
2
1ˆ argmin  - ( )
2
R

 
f
f g Hf f .       (3.15) 
The formulation in Eq. 3.14 can be expressed within the Bayesian framework by defining an 
observation model p(g| f, σ 2) and an image prior p(f) as follows: 
                                            22 2 2
1
p | exp  - 
2
,

 
  
 
g f g Hf  ,                   (3.16) 
    p exp R f f .       (3.17)                                                      
The optimization problem in Eq. 3.15 then corresponds to finding the maximum (the 
mode) of the joint distribution p( g| f, σ 2) = p( g| f, σ 2) p(f), corresponding to a maximum a 
posteriori (MAP) estimation. In the following the Bayesian modeling formulation is followed.  
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Notice that in Eq. 3.15, the signal-independent noise n is modeled as zero-mean, independent 
white Gaussian noise with variance σ2. The Gaussian modeling accurately describes the noise 
characteristics in SLIM, since the signal-to-noise ratio (SNR) is very high (as in fluorescence 
microscopy [83]). In addition, the noise variance σ2 can be estimated experimentally from a 
uniform area in the acquired image. 
As mentioned earlier, the functional R(·) (and thus the image prior p(f)) is used to 
regularize the solution by enforcing certain image characteristics. The inverse filter solution can 
be obtained when no regularization is used (R = 0), but this approach generally does not produce 
good results due to excessive amplification of noise. The role of regularization is to impose 
desired characteristics on the image estimates, and to suppress the noise and ringing artifacts. 
The regularization parameter β controls the trade-off between the data-fidelity and the strength of 
the regularization on the estimates. 
I now present an image model suitable for characterizing both the specimen and the 
image instrument. Phase contrast imaging provides high sensitivity at the sharp object 
boundaries, but it is relatively insensitive to slow-variations in the background region. Thus, 
phase images generally exhibit high contrast around edges corresponding to, e.g., cell 
boundaries, which in turn provides accurate morphological information. In addition, in live cell 
imaging, the specimen contains a fine structure and small-scale dynamics. 
Based on these characteristics, I propose to use the sparse representation/reconstruction 
framework [94] that is suitable for modeling phase images. Sparse representation and 
reconstruction have recently been used in a number of imaging problems with great success (e.g., 
[95, 96]). It has also been shown [95, 97] that sparsity-based deconvolution is generally superior 
to classical methods based on Wiener filtering and Tikhonov regularization.  
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As demonstrated below, phase images can be accurately represented sparsely in some 
transform domain; that is, when an appropriate transform is applied to the images, most of the 
transform coefficients become very small while only a few contain most of the signal energy. 
This transform sparsity allows us to capture the characteristics of spatial variations within the 
image. In this work, I use a collection of L linear transforms Dk with k = 1, ..., L, which are 
chosen as difference operators that capture spatial variation at varying scales and orientations. 
Specifically, I use the first and second order directional difference operators  
 1 1 ,  1 2 1             (3.18) 
and 45o and −45o first-order derivative filters 
1 0
0 1
 
 
 
, 
0 1
1 0
 
 
 
                   (3.19) 
These 2D transforms are applied on all three planes in the image, that is, on x−y, y−z and 
x−z planes, which in total give 12 transforms to capture the local spatial variations within the 3D 
structure. More complicated transforms can also be incorporated in the proposed framework in a 
straightforward manner. As an illustration of the sparsity property of phase images, a SLIM 
phase image and the output of applying difference operators (in x-, y- and z- directions) are 
shown in Fig. 3.5, along with the corresponding log-histograms. It is evident that most of the 
structural information is accurately captured by the filtered images. In addition, the cell structure 
concealed in the acquired phase image is revealed in the filtered images (especially in the z-
direction). Notice also that compared to the SLIM image, the sparsity level is significantly 
increased and the decrease in resolution due to the PSF can clearly be observed in the filtered 
images.  
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Figure 3.5. Sparsity property of phase images. Images show the original phase image, and the output 
images obtained by applying first order directional derivatives in the x, y, and z directions, as labeled, 
scale bar is 1 µm. The plot shows the corresponding log-histograms, the increase in sparsity is clearly 
visible. 
Using these transforms, the image model can be constructed to exploit the sparsity in the 
transform coefficients. In this work, I employ separate Gaussian priors on each transform 
coefficient as 
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where ki  are the weighting coefficients. The prior in Eq. 3.19 can be expressed in a more 
compact matrix-vector form as 
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where Ak are diagonal matrices with ki ,i= 1, . . .N in the diagonal. The prior in Eq. 3.19 
constitutes a sparse image prior, since the transform coefficients (Dkf)i at pixel i are suppressed 
when the corresponding weight ki  assumes very large values.  
The weights ki  also represent the local spatial activity at each location, and hence they 
are a measure of spatial variation in the corresponding filters direction. Since I do not know a 
priori which transform coefficients should be suppressed, they are estimated simultaneously with 
the image. For their estimation, I assign uniform priors as  
p( ) const, ,ki k i   .      (3.22) 
It should be noted that this image modeling based on the sparsity principle is used solely 
as an image prior, and it does not necessarily result in image estimates that are sparse in the 
transform domains. This is because the image estimate is still constrained with the acquired 
image g via the data constraints (the first term in Eq. 3.14). Real images are generally only 
approximately sparse, with a few transform coefficients containing the majority of the image 
energy while the remaining majority of the coefficients have very small values. These small 
values may carry information about the subtle image features. The modeling employed in this 
work allows for adaptively estimating both the large and small coefficients by estimating the 
parameters ki  simultaneously with the image. 
Using the models for the noise in Eq. 3.15, the image in Eq. 3.21, and the parameters in 
Eq. 3.22, the problem of estimating the unknown complex image f and the weights ki  is 
formulated within the MAP framework as 
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I solve this problem using an alternating iterative minimization scheme where each 
unknown is estimated by keeping other variables fixed. Notice that this problem is convex in f 
and αki, but it is not jointly convex. For such problems, alternating minimization is shown to be 
an effective strategy, and it converges to a local minimum of the objective function (see [98, 99] 
for related discussions).  
The estimate of the complex image f is found by taking the derivative of Eq. 3.24 and 
setting it equal to zero, which yields 
1
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The parameters ki  are estimated in a similar fashion by minimizing Eq. 3.24, which 
gives the update 
      
 
2
k
ˆ
1
ˆ =ki
i

D f
,       (3.26) 
where ε is a small number (e.g., 10-6) used to avoid the trivial solution ( 1ˆ =0ki
 ) for numerical 
stability. It is evident from (14) that the parameters ki  are functions of the k
th filter response at 
pixel i of the image estimate fˆ . Thus, the strength of the enforced sparsity is varied spatially 
within the image, and it is adaptively estimated with each new image estimate. Through the use 
of the transforms, this can also be seen as controlling the amount of spatially-varying smoothness 
applied on the image estimate: When a parameter ki  assumes a large value, a higher amount of 
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smoothness is applied at pixel i (and vice versa). Low values of ki  will therefore be obtained in 
the areas with more edge structure, preserving the image features.  
 
Figure 3.6 Three-dimensional point spread function. (a) Comparison of raw and deconvolved. PSF in 
the x-y plane; the deconvolution process reduces the FWHM from 397 nm to 153 nm. (b) Comparison of 
raw and deconvolved PSF in the x-z plane; the deconvolution process reduces the FWHM from 1218 nm 
to 357 nm. The dashed lines show the data and the circular markers indicate the Gaussian fit used to 
determine the FWHM. 
In summary, the dSLIT deconvolution method estimates the complex image f using Eq. 
3.24 and the parameters ki  using Eq. 3.25 in an alternating fashion. Estimation of the image in 
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Eq. 3.25 is performed using the conjugate gradient (CG) method. The operations involving the 
products with matrices H and Dk are done via multiplications in the Fourier domain. As 
mentioned earlier, the noise variance σ2 is estimated from an approximately uniform background 
region in the image. The alternating minimization method employed here can be shown to 
belong to the family of half-quadratic minimization methods, for which certain theoretical 
convergence guarantees exist [98, 99]. The method is initialized with the acquired phase image g 
without any pre-processing. Since the noise level in SLIM is very low, this image is a good 
estimate of the sharp image. In addition, the experimentally obtained point spread function (PSF) 
h accurately represents the true PSF (see next section). Empirically I found that the proposed 
deconvolution algorithm is very robust and generally converges very rapidly within a few 
iterations. Finally, note that since the deconvolution is applied directly in the complex image 
domain, dSLIT does not alter the quantitative imaging property of SLIM. In contrast, traditional 
deconvolution methods applied on intensity images cannot preserve the quantitative information. 
To quantify the increase in resolution I applied dSLIT to the experimentally measured 
point spread function (PSF). The experimental PSF was acquired by using SLIM to measure a 
sub-resolution (150nm) diameter polystyrene bead, while scanning the focus in z in increments 
of 200 nm. Figure 3.6 shows the results of the deconvolution, the FWHM were calculated by 
fitting the experimental results with a Gaussian. In the x-y plane (Fig. 3.6a) an increase in 
resolution of 2.5 times is achieved as the FWHM is decreased from 397 nm to 153 nm. In the 
axial (z) direction the FWHM is reduced from 1218 nm to 357 nm, corresponding to an increase 
in resolution of 3.4 times that of SLIM (Fig. 3.6b). Next the method was evaluated on a 
biological specimen. 
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E. coli cells were prepared and imaged as described in Appendix A. Figure 3.7a shows a 
comparison of the SLIM and dSLIT images from two cells at different z- positions. It is clear 
that the deconvolution process reveals subcellular structure that is not visible in the SLIM 
images. Figure 3.7b shows the center slice of the 3D Fourier transform of the SLIM and dSLIT 
data. As discussed above SLIM measures the complex field at each z-position; thus the intensity 
distribution in far field or the scattering plane may be determined by calculating its Fourier 
transform, a technique known as Fourier transform light scattering (FTLS) [100]. Comparing the 
scattering maps obtained from the SLIM and deconvolved data, it is clear that there is more 
information available at higher scattering angles or spatial frequencies corresponding to smaller 
structures. Thus combining dSLIT with FTLS provides scattering information at the sub-cellular 
level for single E. coli. To our knowledge the scattering from single E. coli and their sub-cellular 
structures has not been studied, probably due to the practical difficulties involved in performing 
such measurements.  
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Figure 3.7. Comparison of raw and deconvolved data from two cells. (a) SLIM and dSLIT images at a 
variety of z-positions, with clearly visible coiled structures. (b) Scattering maps corresponding to the 
images shown in A. The increase in resolution is clearly visible from the extra information at higher 
angles in the dSLIT maps.  
The dSLIT data reveal two sets of subcellular coil-like structures that are visible in most 
of the cells that were analyzed; Fig. 3.8 summarizes the measurements made on these structures. 
In the x-y plane a coiled structure is observed with an average period of 430 nm. Although the 
clarity and completeness of the structure vary from cell to cell, the period of the structure was 
measured to be invariant with the length of the cell. In the x-z plane another coil-like structure is 
apparent, which was measured to have a period of approximately half the length of the cell. This 
structure is not readily visible in smaller or freshly divided cells. The differences observed in x-y 
and x-z plane are likely due to the difference in resolution of the method in the axial and lateral 
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planes. Such coil-like structures have been observed in several contexts in E. coli cells including 
the MreB cytoskeletal element, MinCDE coiled arrays, outer membrane proteins and 
lipopolysaccharide [89, 93]. Fluorescence measurements of these structures indicate that they are 
most likely functionally distinct though little is known about their temporal behavior.  Although 
dSLIT reveals these structures, there is no way to truly determine from the current data what the 
structures truly are. For this, it is necessary to conduct a study in which different subcellular 
structures are fluorescently labeled. Once the identity of the structure is determined, it will then 
be possible to study it in a label-free manner using dSLIT. This will enable practical experiments 
of the behavioral dynamics of these sub-cellular structures without the need for specialized 
strains or probes. 
 
Figure 3.8. Measurement of prominent structures found in 26 cells. In the x-y plane a coil structure is 
visible that has a period of approximately 0.43 µm and does not vary with the length of the cell. In the x-z 
plane another structure is visible that has a period of half the cell-length. 
In summary, dSLIT is a novel deconvolution microscopy method that retrieves sub-
diffraction limited resolution information from the complex fields measured by SLIM. dSLIT 
operates on three key observations. First, the degradation of the image by a microscopy PSF can 
be modeled as a linear process. Second, due to the high SNR characteristic of SLIM, this PSF 
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may be measured experimentally. Third, the quantitative phase measurements of thin biological 
specimen, like E. coli cells, can be accurately modeled using sparsity principles. These properties 
of the measurement system allow for a very effective deconvolution process with a 2.5x 
resolution increase in the longitudinal resolution and a 3.4x increase in axial resolution, as shown 
in Fig. 3.6. This increase in resolution allowed us to measure sub-cellular structure in E. coli that 
was previously not visible in the SLIM data. Using dSLIT we found two consistent coil-like 
subcellular structures in E. coli, one that retains a constant period as the cell grows and one with 
a period of approximately half the length of the cell.  Although several such structures have been 
previously identified, little is known about their function and behavior due to the practical 
difficulties involved in imaging them. The results presented here indicate that dSLIT can be used 
to characterize and study such sub-cellular structure in a practical and non-invasive manner, 
opening the door for a more in depth understanding of the biology.  
3.7 Discussion 
In summary, QPI and especially SLIM has expanded the capabilities and potential applications 
of quantitative phase imaging by providing high resolution speckle-free measurements. Due to 
this, SLIM has provided information with unprecedented detail on the structure and dynamics of 
living systems and has enabled many exciting biological applications. The major advances 
provided by SLIM and the analysis tools discussed here are: 
1) Speckle-free images providing 0.3 nm spatial sensitivity to changes in optical path length 
2) Temporal stability of 0.03 nm due to common path setup 
3) 3D tomography due to inherent depth sectioning 
4) Multiplexing with other microscopy modalities 
5) Femtogram sensitivity to dry mass changes 
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6) Label-free measurements of mass transport 
7) Single shot scattering measurements 
In the remainder of this thesis I will show how these capabilities can be leveraged to 
construct novel clinical tools and address fundamental questions in cell biology. 
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CHAPTER 4. RED BLOOD CELL CYTOMETRY* 
Existing clinical technologies used to characterize patient blood such as impedance 
counters and flow cytometers, though very effective in terms of throughput, offer limited 
information, are expensive, bulky, and costly to maintain, and often require careful calibration. 
Though there have been reports of using high throughput cytometers to characterize red cell 
morphology [101], this approach is limited as it only provides a general description of shape 
(e.g., ellipsoid vs. spherical) and is unable to provide the resolution required for aiding in 
differential diagnosis. Automated counters are thus designed to produce accurate measurements 
of normal blood and to alert the technician with “flags” when numerical abnormalities exist so 
that a smear may then be prepared and examined [102]. Even though automated blood analyzers 
have reduced the number of samples that require smears to 15%, the examination of a smear is 
still an indispensable tool in providing differential diagnosis (commonly for anemias and 
thrombocytopenia), recommending further tests, speedy diagnosis of certain infections and the 
identification of leukemia and lymphoma [103]. Despite the ability of the automated instruments 
to measure volume and hemoglobin concentrations, they are unable to accurately measure 
morphologic abnormalities and variations in shape, at the single cell level, and thus a pathologist 
is required to manually examine a smear. Other modern methods that can be used for accurately 
assessing red cell morphology, such as confocal microscopy, suffer from complicated procedures 
and the need for using specialized exogenous contrast agents. 
The use of the optical phase shift through a sample as an endogenous contrast agent has 
served as a powerful technique in microscopy since the advent of techniques such as phase 
contrast (PC) and differential interference contrast (DIC) microscopy [104]. Even though these 
                                                            
* Portions of this chapter have been reproduced here from my master’s thesis (M. Mir, 2009) and the below 
referenced material in order to introduce the material in a complete manner. This material is reproduced with the 
permission of the publisher. 
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modalities greatly enhance the ability to observe details within transparent objects such as living 
cells, it was not until the development of quantitative phase imaging (QPI) techniques that the 
phase shift through a sample was able to provide quantitative information. Furthermore, with the 
development of common path interferometry and methods such as diffraction phase microscopy 
(DPM) [8] and SLIM [12] (see Chapter 2), we can now obtain quantitative phase images that are 
sensitive to sub-nanometer changes in optical path lengths over broad temporal scales.  
4.1 Diffraction Phase Cytometry*  
In this section I described Diffraction Phase Cytometry (DPC) which is based on DPM, 
and produces accurate measurements of normal blood and in addition is capable of 
characterizing specific morphological abnormalities in diseased blood. I previously demonstrated 
the simplicity and versatility of the DPM technique by combining it with CD-ROM technology 
for characterizing red blood cells (RBCs) [105]. By giving access to detailed 2D and 3D 
morphological parameters such as volume, surface area, sphericity, diameter, etc., DPC provides 
new information that is currently unavailable from commercial instruments. It is known that the 
distributions of these parameters and correlations between them reveal physiologically important 
information about a given blood sample [106]. For example, the minimum cylindrical diameter 
(MCD) can be used to predict the minimum capillary diameter that a given cell can squeeze 
through [107].  
We present a comparison between the abilities of the DPM system and a state-of-the-art 
clinical impedance counter to measure and characterize RBCs. It is shown that after taking the 
mean cell hemoglobin concentration (MCHC) into account the DPM data correlates very well 
with the impedance counter. The advantages of using the DPM are also illustrated by an analysis 
                                                            
* A modified version of this chapter has appeared in M. Mir, H. Ding, Z. Wang, J. Reedy, K. Tangella and G. 
Popescu, Blood screening using diffraction phase cytometry, J. Biomed. Opt., 15 (2), 027016 (2010). This material 
is reproduced with permission of the publisher. 
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of the volume and sphericity distributions obtained from two patients. DPM also has the 
advantage that it can be easily implemented as an add-on modality to a microscope without 
adding any additional preparatory steps to the lab workflow. The results shown here are from 
measurements on whole blood samples, further illustrating the flexibility of the technology, as it 
can be applied both to peripheral blood smears and to samples stored according to clinical 
protocols. Considering the agreement with current techniques and the detailed morphological 
information provided by the DPM, it could prove to be both a powerful diagnostic tool and a way 
to improve blood testing efficiency by reducing the number of cases that require a manual smear 
analysis.  
Whole blood was drawn from patients at a local community hospital via venepuncture by 
a certified phlebotomist and is stored in EDTA coated containers at room temperature. A 
complete blood count (CBC) analysis was then performed on each sample with the Coulter LH50 
(Beckman-Coulter) impedance counter used for routine analysis in the hematology lab at the 
hospital. Each sample was marked with a unique identifier, and all unique personal patient 
information (name, id#, etc.) was removed in compliance with HIPPA regulations and the 
University of Illinois Institutional Review Board to maintain patient confidentiality. 
The whole blood was then diluted with the same Coulter LH series diluent (Beckman 
Coulter) used by the impedance counter for a final concentration of 0.2% whole blood in 
solution. This concentration was chosen as it provides an adequate cell count for comparison 
with the CBC while being low enough to provide sufficient distribution of the cells, which is 
necessary for proper analysis given the large variations in patient hematocrit. Following dilution, 
the sample is pipetted into a 200 µm tall chamber, which was made in house by punching a hole 
in double-sided Scotch tape (3M) and sticking one side of the tape to a cover slip. After the 
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sample was introduced to the chamber, it was sealed using another cover slip. This sealed 
chamber technique reduces the mechanical stress imposed on the cells during sample 
preparation, offers precise control over the sample volume, prevents drying, and reduces cell 
translation. The samples were measured 5 minutes after being sealed to allow them to settle to 
the bottom of the chamber and to reach a steady state in the solution. 
The DPC setup utilized in this experiment uses the diffraction phase microscope [8, 100] 
as its core platform. In short, the DPC setup is a common path interferometer, in which a 
diffraction grating located at the image plane of a microscope is used to generate diffraction 
orders, each containing full spatial and phase information of the sample. The 0th order or un-
deviated beam is then spatially low-pass filtered using a pinhole in the Fourier plane so that it 
can be used as a reference beam; the +1  diffraction order is used as the sample beam and all the 
other orders are blocked. A second lens is then introduced to project the interferogram onto the 
CCD plane for recording. The phase map of the sample is then retrieved from a single CCD 
exposure by applying a spatial Hilbert transform [7]. 
For each sample, 1600, 32 µm x 32 µm interferograms were recorded, which cover a total 
area of 1.64 mm2; a total of 5.3 minutes is required to scan this area at a rate of 5 frames/s. The 
analysis of the phase images is carried out in MATLAB (The Mathworks 2008) using a cell 
detection and analysis software developed in house. To find the cells in each image a standard 
particle detection algorithm was used [108]. Once the pixels occupied by individual cells are 
identified we can proceed to quantify the 2D and 3D morphological parameters of each cell. The 
2D parameters such as diameter, projected area and circularity are easily obtained using region 
property descriptors available in MATLAB.  
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In order to obtain physiologically relevant and accurate 3D parameters from the retrieved 
phase map it was translated to a height map using an index of refraction calculated based on the 
mean cell hemoglobin concentration of each sample, as measured by the impedance analyzer. 
Due to the linear dependence on the protein concentration [41], the refractive index can be 
calculated as 0 *cn n MCHC  , where β is the refractive increment of hemoglobin (0.002 
dL/g) and MCHC is the concentration of dry protein expressed in g/dL. The phase map φ(x,y) is 
then translated to a height map h(x,y) using the contrast in refractive index between the cells and 
surrounding media, Δn: ( , ) ( , )
2
h x y x y
n





, where λ =532 nm is the wavelength of the 
illumination and Δn=nc-n0. Once the height information is retrieved, the volume of each cell is 
calculated by integrating the height map over the projected area as ( , )V h x y dxdy  . The 
surface area of individual cells is determined using Monge parameterization [109], where the 
area of each pixel element, dA, is calculated as 
2 2
1
x y
dA dxdy h h   , where dx and dy are the 
width and height of each pixel and hx and hy are the gradients along the x and y directions 
respectively. The surface area of each cell is then the sum of all the area elements and the 
projected area, assuming the cell is sitting flat on the cover slip. Knowing the surface area and 
volume, we can calculate parameters such as sphericity (ψ) and minimum cylindrical diameter 
(MCD). The sphericity, , of RBCs was first determined as an important parameter by Canham 
and Burton [106]. It is defined as the ratio between the surface area (SA) of a sphere with the 
same volume as the cell, to the actual surface area of the cell, with values ranging from 0 (for a 
laminar disk) to 1 for a perfect sphere, and is calculated as 
2/3
4.84
V
SA
  . The MCD, also 
introduced by Canham and Burton, is a theoretical parameter that predicts the smallest capillary 
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diameter that a given RBC can squeeze through. The MCD is obtained by solving the following 
polynomial equation that defines the cell volume: 
3
*
12
V SA MCD
MCD
  .  
Overall, for each cell imaged we obtain the following 17 parameters: perimeter, projected 
area, circular diameter, surface area, volume, sphericity, eccentricity, minimum, maximum and 
mean height, minimum cylindrical diameter, circularity, integrated density, kurtosis, skewness 
and variance. Thus, it is possible to identify and characterize abnormal cells that would 
otherwise be difficult or impossible to detect manually in a smear. This type of analysis could be 
utilized for early detection of diseases, infections and abnormalities such as poikliocytosis [102] 
and malarial infection [110], or of reactions to treatments such as chemotherapy and bone 
marrow transplants [111]. If manual analysis of the abnormality is still necessary to confirm the 
diagnosis, a physician may simply examine the cell images that have been labeled as abnormal 
by the DPC system, rather than manually scanning a smear in search of abnormalities. Given the 
wealth of information available about each cell, it is possible to study the distributions of and 
correlations between parameters in order to establish the parameters expected from a normal 
sample and to characterize various abnormalities. 
In this study, samples from 32 patients were analyzed using both a clinical Coulter 
impedance counter and the DPC system; with the DPC system we analyzed an average of 828 
cells per sample. We show that there is high correlation between the CBC and DPC data and 
provide examples of the advantages associated with our interferometric, image-based cytometry 
technique. 
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Figure 4.1 MCV values measured by DPC vs. impedance counter (complete blood count, CBC).  The 
DPC data is shown before the correction for the refractive index (Raw) and after refractive index 
correction (Corrected). Pearson correlation coefficients for both data sets are shown in the legend. The 
straight line, included for comparison, represents the CBC MCV values.  
 
In order to evaluate the consistency of the DPC analysis in comparison to that of the 
Coulter counter, we compared the mean corpuscular volumes (MCV) obtained by both methods 
(Fig. 4.1). Initially the data was analyzed assuming a constant refractive index contrast for all 
samples, which resulted in a weak correlation (Pearson correlation coefficient, ρ=0.52) between 
the DPC and CBC volume data (circular symbols in Figure 4.1). However, once the MCHC 
values are taken into account and the refractive index contrast is corrected, the correlation 
improves to ρ=0.84 (triangular symbols in Figure 4.1).  
The MCHC is currently used by pathologists to help diagnose abnormalities such as 
anisochromasia (large variation in MCHC) and spherocytosis (high MCHC) [103]. However, 
with current automated counters a pathologist has to manually examine a smear to confirm 
diagnosis of spherocytosis or any other morphological abnormalities which would result in an 
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abnormal MCHC distribution. With the current DPC system it is possible to provide this 
diagnosis directly using the sphericity index. Figure 4.2 is an example of a sphericity distribution 
obtained from a 97-year-old female patient exhibiting anisocytosis (diagnosed by a large 
variation in MCV). By examining cell images along the sphericity distribution, the capabilities of 
the DPC to differentiate between flat and spherical cells is made clear. If a larger spherocytic 
subpopulation were to exist in this patient, it would appear as a secondary maximum in the 
distribution or could be identified by a positive shift in the samples’ mean sphericity value. 
 
Figure 4.2 Comparison of cells across the sphericity distribution for a 97 y/o female patient exhibiting 
anisocytosis. Examples of cells at the sphericity values as follows: (i) 0.50 (ii) 0.54  (iii) 0.57  (iv) 0.61 
(v) 0.65 (vi) 0.72. 
 
An important advantage of DPC as an emerging technology is that it recovers all metrics 
that are familiar and intuitive to pathologists, such as the MCV. One disorder that is fairly 
common and easy to diagnose using the MCV is anisocytosis, which is characterized by large 
variations in the cell volumes and quantified by the red cell distribution width (RDW). Figure 4.3 
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shows volume distributions from two patients, one normal and one exhibiting anisocytosis. 
Again we show images of cells across the distribution to illustrate the information available 
about each cell.  
 
Figure 4.3. Comparison of volume distributions of patient exhibiting anisocytosis vs. a normal patient. 
The DPC measures red cell distribution width (RDW) values of 12.65 and 16.28 for the normal and 
abnormal patient respectively.  More subpopulations are apparent in the patient with anisocytosis. 
Examples of cells at the different volume peaks as follows: (i) 64 fL (ii) 72 fL (iii) 84 fL (iv) 93 fL (v) 
102 fL (vi) 117 fL. 
 
This type of analysis enables the DPC system to accurately identify the morphological 
abnormalities that are responsible for the anisocytosis. Since anisocytosis could be a result of a 
variety of disorders such as thalassemia (decreased globin synthesis) and myelodisplastic 
syndrome (preleukemia) [103], more detailed information on the cause will aid in a quick and 
early automatic diagnosis of these conditions. 
In summary I have demonstrated the ability of the DPC system to operate as an automatic 
blood analyzer, which recovers the parameters provided by current clinical instruments. We 
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showed that the additional set of parameters measured by DPC offers insight into the nature of 
the numerical abnormalities used to identify morphological disorders. Using this type of analysis 
may aid in an automatic diagnosis of conditions that currently require manual smear analysis. 
Even though the current DPC system has lower throughput and speed than state-of-the-art 
impedance counters, these are practical issues which can be overcome due to the rapid advances 
in automated image acquisition and processing technologies.  
The strong dependence of our results on the cell hemoglobin content indicates that an 
accurate measurement of individual cell protein content needs to be made. A previous method 
entails measuring the cells in two solutions with different refractive indices [112]. Though this 
decoupling method is an effective way to calculate the refractive index, it may be impractical in 
a clinical setting, due to throughput considerations and because exposing the cells to different 
solutions may affect their properties. It has recently been shown that DPC can directly measure 
single cell hemoglobin concentration by either utilizing a broadband source [113] or performing 
DPM at different wavelengths [114]. Both of these techniques rely on the dispersion properties 
of hemoglobin to infer the protein concentration. In Chapter 4.2 I show how it is possible to 
measure both hemoglobin and thickness by combining absorption measurements at one 
wavelength with QPI data. This new method frees DPC from relying on any external 
measurements and thus greatly add to both is practical application in a clinic and its power in 
aiding differential diagnosis. 
4.2 Simultaneous Measurement of Morphology and Hemoglobin* 
As discussed above QPI is capable of providing detailed, quantitative, morphological analysis 
as well as several novel clinically relevant parameters for red blood cells [105, 115-125] at the 
                                                            
* The work shown here has appeared in its entirety in M. Mir,  K. Tangella and G. Popescu, Blood testing at the 
single cell level using quantitative phase and amplitude microscopy, Biomed. Opt. Exp., 2 (12), 3259 (2011). This 
material is reproduced with permission of the publisher. 
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single cell level. However, since the optical phase shift through a red blood cell is a function of 
both thickness and refractive index, the demonstrated morphological analysis has depended on a 
priori knowledge of the hemoglobin concentration [105, 126]. Other groups utilizing phase 
measurements have addressed this problem in various manners. One popular approach utilizes 
two different immersion media to decouple the thickness and refractive index [112, 127, 128]. 
This approach requires that cells be kept in place as the media is changed and thus requires 
coating of the cover slips and a profusion setup. Thus, such a technique may not be well suited 
for clinical measurements especially with the goal of developing a point-of-care diagnostic tool 
in mind. More recently, it has been demonstrated that by acquiring diffraction phase microscope 
(DPM) measurements at different wavelengths, hemoglobin concentration may be quantified at 
the single cell level [114]. This technique, dubbed Spectroscopic Phase Microscopy, is highly 
stable and utilizes a relatively simple experimental setup and is therefore well suited for adoption 
as a clinical method. However, DPM requires modifications to the illumination path of a 
microscope and is not easily integrated with other popular modalities such as fluorescence 
measurements.  
Here I provide the proof of principle of a novel combination of the quantitative phase 
information measured using a Spatial Light Interference Microscope (SLIM) [32, 129], with a 
bright field absorption measurement acquired in the Soret band. We show both theoretically and 
experimentally, that this combination can be used to quantitatively determine both hemoglobin 
concentration and cell morphology at the single cell level. SLIM is a new QPI modality which 
utilizes broadband illumination (400-700 nm, center wavelength of 530 nm) in common path 
geometry. Due to this, SLIM provides the ability to measure optical path length with 
unparalleled sensitivities of 0.28 nm spatially and 0.029 nm temporally [16]. Furthermore, SLIM 
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is designed as an add-on module to a commercial microscope and can easily be integrated with 
other commonly used modalities. 
The method described here may be deployed as a standalone blood smear analyzer in a 
clinical setting without relying on external measurements of hemoglobin concentrations. The 
additional set of measured parameters may offer insight into the nature of morphological 
abnormalities used to identify various disorders and will likely automate the diagnosis of 
conditions that currently require manual smear analysis. Such a method may be implemented for 
a fraction of the cost of current analyzers, requires no reagents or complicated sample 
preparation and has the potential to easily be adapted to a compact and portable platform [105, 
122]. The technique presented here may be also utilized with any QPI instrument, provided that 
it meets the resolution and sensitivity requirements for single erythrocyte analysis. 
The phase measured by SLIM is related to the refractive index and thickness of the sample as 
                                                          
0( , ) ( , ) ( , )x y k n x y t x y                       (4.1) 
where k0=2π/λ and λ is the mean wavelength, t is the thickness and Δn=(βC+nw)-ns. Here β is the 
refractive increment of protein in mL/g, C is the concentration in g/mL, nw is refractive index of 
water and ns is the refractive index of the surrounding media. The refractive increment is defined 
as the increase in refractive index per one percent increase in the concentration [130-133]. It was 
shown in the 1950s that the refractive increments of a wide range of proteins lie within the range 
of 0.17 and 0.20 [130-133]. Furthermore, this is also true for other cellular components such as 
lipids and carbohydrates to the point that we may assume that the bulk refractive index of a 
living cell is a good measure of the total dry mass of the cell [17-21]. Given the small variations 
in refractive increment, Eq. 4.1 can be rewritten in terms of the concentration and refractive 
increment as: 
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                        0( , ) ( , ) ( , )wsx y k C x y n t x y     ,                   (4.2) 
where Δnws=nw-ns is the difference between the refractive index of water and the surrounding 
media. The absorption measurements may be described according to the Lambert-Beer law: 
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where A is absorbance, σ is the absorption cross section perpendicular to the optical axis and N is 
the density of absorbers. The relationship between absorption cross section, density and 
refractive index is σN=2k0n”, where n'' is the imaginary part of the refractive index which 
describes the absorption phenomenon. For liquid solutions the absorbance is typically expressed 
in terms of a molar extinction coefficient: 
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where ε is molar extinction coefficient in L∙mol-1cm-1 at the wavelength being used, M is the 
molar mass (g/mol) and C is the concentration (g/L). It can be seen that the only unknowns in 
Eq. 4.2 and Eq. 4.3 are the thickness, t and concentration C. Therefore we may simply solve for 
both: 
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Thus, for a single molecular species case, as in the case of the almost homogeneous red blood 
cell, only one absorption and one phase measurement is necessary to determine both the 
thickness and the concentration.  
To verify this method blood samples were prepared as described in Section 4.1 [126]. For 
measuring the quantitative phase map, SLIM was used, which has been described in detail 
previously [32, 129]. To ensure that the phase measured is integrated over the entire thickness of 
the cell I used a low numerical aperture (NA) objective. Thus, for both the SLIM and absorption 
measurements a 10x/0.3 Ph1 objective was used. For measuring the absorption map a bandpass 
filter centered at 430 nm (+/- 10 nm) is introduced into the light path after the condenser field 
diaphragm as shown in Fig. 4.4. In principle any bandpass filter could be used, provided the SNR 
is high enough. The choice of 430 nm was made since it is strongly absorbed by both oxygenated 
and deoxygenated hemoglobin. The phase contrast annulus in the condenser is also swung out of 
position so that the illumination is set for bright-field measurements. In order to optimize the 
absorption measurement, both the NA of the condenser and the objective must be taken into 
account. As for the SLIM measurement the NA of the objective must be chosen such that the 
depth of field is greater than the thickness of the red blood cells. The optimal NA for the 
condenser was determined experimentally by varying NA between 0.55 and 0.1 and measuring 
the absorption. It was found for multiple objectives (data not shown) that the absorption 
continues to increase as the NA is decreased and peaks at a value close to the NA of the 
objective being used. After this point, aberrations become clearly observable in the image. For 
the 10x/0.3 objective used here, the value for the condenser NA which gave the greatest contrast 
was determined to be 0.2.  
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Figure 4.4. Experimental setup. The SLIM system is built as an add-on module to a commercial phase 
contrast microscope. The back focal plane of the objective is projected onto a spatial light modulator 
which is calibrated to impart a phase shift to the un-scattered light (yellow lines) relative to the scattered 
light (shown in red). Four intensity images are recorded corresponding to 4 phase shifts in increments of 
π/2, the quantitative phase map is reconstructed from these 4 intensity images as detailed in Ref. [129]. 
For the SLIM measurements the illumination type is set to phase contrast and the filter wheel is set to an 
open position such that the entire spectrum of the halogen lamp is passed. For the absorption 
measurements the illumination type is set to bright field and a 430 nm filter is used in the filter wheel. 
The inset for the filter wheel shows the normalized intensity of the white light spectrum, the spectrum of 
the 430 nm bandpass filter (right axis) and the extinction coefficients of oxygenated and deoxygenated 
hemoglobin (left axis) as a function of wavelength from Ref. [134]. 
Although in principle any QPI technique could be coupled with an absorption measurement to 
yield results similar to those shown here, we used SLIM for two main reasons. First, the white 
light illumination used for SLIM allows for easy integration of a filter wheel into the setup to 
70 
 
perform absorption measurements. Second, SLIM provides the lowest noise and highest 
sensitivities out of any QPI technique that we are aware of.   
 
Figure 4.5. Image analysis (a) Quantitative phase map acquired using SLIM, color bar is in radians. (b)  
Absorption map acquired at 430 nm, color bar is in 16-bit gray scale values. (a-b) Insets show an example 
of a single RBC from the maps. (c) Overlay of l line profiles drawn through the center of a single cell, the 
phase values are shown in red against the left axis and the corresponding intensity from the absorption 
maps are shown in black against the right axis. (d) Average absorption vs. phase for each of the 7 patients 
analyzed in this study, a strong linear relationship (dotted line) indicates the feasibility of this method. 
To analyze the images, a semi-automatic image routine was developed in MATLAB. A user 
selects several cells in every image, avoiding cells that are turned on their side or appear 
otherwise damaged. Once a cell is picked the region occupied by the cell is identified by 
generating a binary mask and the center of mass of this mask corresponds to the center of the 
cell. For each cell a horizontal and vertical line profile are then measured through the center, for 
both the absorption and phase map (Fig. 4.5c). This approach assumes that the cells are radially 
symmetric, which is a reasonable approximation for red blood cells, although for future clinical 
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work a pixel by pixel comparison will be ideal. From the phase profiles the peak values were 
chosen and from the intensity profile the minima are chosen. As can be seen in Fig. 4.5c, the 
phase and absorption profiles are in good agreement except in the dimple region of the blood 
cell. For this reason, to demonstrate the feasibility of this technique just the peak values were 
chosen for the analysis presented here. Of course, for clinical translation, this mismatch must be 
understood and addressed; Fig. 4.5d shows that the phase and absorption measurements are in 
fact linearly related and proves the feasibility of this approach. 
The peak values from the horizontal and vertical profiles are averaged and plugged into Eq. 
4.5 and Eq. 4.6 to calculate the un-calibrated concentration and thickness values. For this 
analysis it was assumed that the blood cells are oxygenated and we obtained the absorption 
spectrum for hemoglobin from Ref. [134]. The volume for each cell was calculated by 
multiplying the average thickness, calculated from the line profiles, by the projected area of the 
cell. For calibration, the measured mean cell volume (MCV) and mean cell hemoglobin 
concentration (MCHC) values were plotted against the values reported by the CBC and a best fit 
line is calculate to provide a calibration function. In principle this analysis could be completely 
automated as previously shown [105, 126], but is not necessary for the proof of principle of this 
technology. 
For this study, samples from a total of 7 patients were measured and total of 651 cells were 
analyzed with an average of 93 cells per patient. The comparison between the calibrated mean 
values from our measurements and the CBC values is shown in Fig. 4.6. It can be seen that both 
the measured MCV and MCHC agree well, with R2 values of 0.86 and 0.79, respectively. The 
discrepancies are likely due to two major reasons. First, the MCHC reported by the clinic is 
calculated by lysing all the blood cells to make a solution of hemoglobin. An absorption 
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measurement was then made on this solution to calculate the hemoglobin concentration. 
Therefore, this measurement does not take into account any variability in hemoglobin 
concentration between cells. Secondly, the number of cells measured in this study is relatively 
low compared to the large numbers measured by the clinical impedance counters. Since the 
comparison between our measurements and the clinic relies on calibration, the agreement will 
likely increase with an increase in throughput. 
 
Figure 4.6. Comparison of measured mean values with clinically reported values. (a) Mean Cell Volume, 
red error bars correspond to the SD reported by the Clinic and black error bars correspond to SD 
measured by the QPI and absorption measurements. (b) Mean Cell Hemoglobin Concentration, error bars 
correspond to the measured SD, no SD information on the hemoglobin concentration is available from the 
Clinic. The dashed black lines have a slope of one. 
 
For the volume measurement, Fig. 4.6a also shows the standard deviations measured by the 
clinic in red and those measured by our technique in black. The lack of perfect agreement in the 
distribution widths is most likely due to the higher sensitivity of our method and the difference in 
the sample sizes measured. Although the clinical counter we are comparing our measurement to 
does provide a histogram of size distributions for each patient, it does not have the capability to 
do the same for hemoglobin concentration; Fig. 4.6b thus only shows the standard deviations in 
the hemoglobin concentration distributions measured by our technique. The fact that the clinical 
analyzer in a major community hospital does not have this capability illustrates the need for a 
simple approach to provide this measurement.  
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In this section I have shown both theoretically and experimentally that by combining 
quantitative phase measurements with bright field absorption measurements it is possible to 
calculate both cell morphology and hemoglobin concentration at a single cell level. The method 
was validated by comparing the values measured with those reported by a state-of-the-art 
automated clinical blood analyzer. Although in this study a calibration was necessary, in the 
future a more detailed understanding of the formation of the bright field image may render this 
step unnecessary. In particular, the measured intensity includes contributions from scattered light 
and is not a pure absorption map as described by Beer's law. Furthermore, Lambert-Beer's law 
must be rewritten for the case of convergent illumination as is provided by a typical microscope. 
The fact that the phase and absorption are linearly related, without taking these effects into 
account, indicates that the contribution from them is constant for red blood cells.  
Although I used SLIM to measure phase, in principle this technology could be utilized in 
combination with any QPI method. However, SLIM is well suited for this method since it does 
not require any modifications to a commercial microscope and the filter wheel required for the 
absorption measurements may easily be integrated with the white light illumination. The fact that 
SLIM requires 4 intensity measurements is only a practical issue as the advent of fast spatial 
light modulators, cameras and scanning software means that the speed of the measurement may 
easily be increased. Furthermore, the high SNR provided by SLIM ensures that data analysis 
technology can easily be automated to increase throughput. Since SLIM can simply be added as 
a modality to an existing microscope, minimal re-training will be necessary to use the equipment, 
especially given that the parameters provided by this analysis are already familiar to pathologists 
and technicians.  
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The technology presented here offers a powerful new blood screening tool that may aid 
pathologists in making differential diagnosis and risk stratification. This technology combined 
with the morphological analysis described previously [105, 126] provides the ability to analyze 
red blood cells with unprecedented details and may enable new diagnostic capabilities when 
monitoring and treating red blood cell disorders. Furthermore, the ability to easily measure single 
cell hemoglobin concentrations may open new avenues for monitoring blood cell disorders and 
the effects of treatment.  
4.3 Discussion 
In this chapter I have shown that QPI offers a powerful new blood screening utility that 
can be used to aid in making differential diagnosis by an experienced pathologist. QPI 
instruments can be simply added on as a modality to any existing microscopy, and no special 
sample preparation is necessary to integrate it into the clinical workflow. Furthermore, the 
outputs of QPI blood measurements are intuitive morphological characteristics, such as 
sphericity and skewness, meaning that no new specialized knowledge is necessary to take 
advantage of the added information. Recently others in our group have shown that blood analysis 
may be performed in real time, further demonstrating the abilities of this technology to be 
deployed as a point of care tool. Advancements in spectroscopic measurements, image 
processing and computing power will continue to augment the abilities presented here, while 
maintaining its position as a low cost, high throughput and highly sensitive instrument. 
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CHAPTER 5. CELL GROWTH* 
Single cell growth regulation has been described as "One of the last big unsolved problems in 
cell biology" [135] and the ability to measure the growth rate of single cells is integral to 
answering this question [54, 120, 136, 137]. The age-old debate is whether the growth rate is 
constant through the life-cycle of a cell (linear growth) or grows proportionally with the cell 
mass (exponential growth) [138-144]. Each growth pattern carries its own biological 
significance: if the growth is linear, cells do not need machinery to maintain homeostasis; on the 
other hand, exponential growth requires checkpoints and regulatory systems to maintain a 
constant size distribution [139]. This can be understood simply by considering two daughter cells 
of different size: under exponential growth the larger of the two would grow faster and thus the 
variability would increase with each generation; thus a mechanism to regulate growth must be 
present. The reason that this debate has persisted despite decades of effort is primarily due to the 
lack of quantitative methods to measure cell mass with the required sensitivity. In order to 
distinguish an exponential pattern from a linear one, it has been calculated that a resolution of 
less than 6% in cell size is required [52]. 
 Until recently, the state-of-the-art method to assess a single cell growth curve was using 
Coulter counters to measure the volume of a large number of cells, in combination with careful 
mathematical analysis [52]. For relatively simple cells such as Escherichia coli (E. coli), 
traditional microscopy techniques have also been used to assess growth in great detail [53]. In 
this type of method the assumption is that volume is a good surrogate for mass; however, this 
assumption is not always valid, for example due to variations in osmotic pressure [120]. 
Recently, shifts in the resonant frequency of vibrating microchannels have been used to quantify 
                                                            
* This chapter appeared in its entirety (with some modifications) in M. Mir, Z. Wang, Z. Shen, M. Bednarz, R. 
Bashir, I. Golding, S. Prasanth and G. Popescu, Optical measurement of cycle-dependent growth, Proc. Natl. Acad. 
Sci., 108 (32), 13124 (2011).  This material is reproduced with the permission of the publisher. 
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the buoyant mass of cells flowing through the structures [54, 55]. Using this approach, Godin et 
al. have shown that several cell types grow exponentially; i.e., heavier cells grow faster than 
lighter ones [54]. However, while this method is sensitive enough to measure bacteria growth, it 
cannot be applied to adherent cell lines. Later, Park et al. extended this principle to allow mass 
measurements on adherent cells [136]. This benefit comes at the expense of sensitivity (e.g., it 
cannot measure single bacterium growth), and throughput (it measures single cells at a time). An 
ideal method will perform parallel growth measurements on an ensemble of cells simultaneously 
and continuously over more than one cell cycle, quantify possible cell cycle phase-dependent 
growth, apply equally well to adherent and non-adherent cells, and work in a fully biocompatible 
environment [52, 54]. Here we demonstrate that a new imaging method developed in our 
laboratory, Spatial Light Interference Microscopy (SLIM) [145], approaches these ideals. 
The principle behind using interferometry to measure cell dry mass was established in the 
early 1950s when it was recognized that the optical phase shift accumulated through a live cell is 
linearly proportional to the dry mass (non-aqueous content) of the cell and has since then been 
used by many groups to monitor cell dry mass [39, 58, 146-148]. In the past decade or so, 
quantitative phase imaging methods have advanced rapidly (see, for example Refs.  [149, 150] 
and references therein) and new biological applications have been explored [43, 151, 152]. 
However, despite these advances, two main limitations commonly affect the performance of 
quantitative phase imaging: (i) reduced contrast due to the speckle generated by the laser sources 
and (ii) the complexity of the experimental setups limits their adaptation in biological settings. 
SLIM overcomes these challenges by combining traditional, white light phase contrast 
microscopy with holography, thus providing speckle-free quantitative phase maps (for details on 
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the operating principle of white light interferometry and SLIM, see Chapter 2, Refs. [14, 145, 
153, 154] and Appendix C). 
Recently, it has been shown, both theoretically and experimentally, that the surface 
integral of the cell phase map is invariant to small osmotic changes [120], which establishes that 
quantitative phase imaging methods can be used for dry mass measurements. The dry mass 
density at each pixel is calculated as ( , ) ( , )
2
x y x y

 

 , where λ is the center wavelength,  
is the average refractive increment of protein (0.2 ml/g) [120] and φ(x, y) is the measured phase. 
The total dry mass is then calculated by integrating over the region of interest. Remarkably, 
SLIM’s pathlength sensitivity of 0.3 nm spatially (pixel to pixel) and 0.03 nm temporally (frame 
to frame) [145] translates into spatial and temporal sensitivities of 1.5 fg/m2 and 0.15 fg/m2, 
respectively.  
5.1 E. coli Growth 
In order to demonstrate that SLIM can recover cell growth results on a well-studied model [54], I 
imaged E. coli cells growing on an agar substrate at 37 °C. The evolution of single cells was 
tracked using the Schnitzcell semi-automatic software (Michael Elowitz, Caltech). Figure 5.1aA 
shows the dry mass growth curves for a family of E. coli cells. The negative mass densities are 
due to the fact that our measurements are always with respect to a baseline value of the 
surrounding medium which is of zero-average. As a control I also measured fixed cells under the 
same conditions from which we retrieved a standard deviation of 19.6 fg. Note that, because of 
the noise introduced by the culture environment, this error is larger than intrinsically allowed by 
the optical instrument. Figure 5.1b shows the growth rate of 22 single cells as a function of mass,
( ) /dM t dt . The average of the data (black circles) shows that the growth rate is proportional to 
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the mass, ( ) / ( )dM t dt M t , indicative of exponential growth. Prior to calculating the 
derivative, the raw data (markers) in Fig. 5.1a is first time-averaged (solid line). These results are 
in excellent agreement with recent measurements by Godin et al. [54] and demonstrate that 
SLIM can measure dry mass with the precision necessary for answering such biological 
questions. Note that my measurements are performed simultaneously on many individual cells 
and can be performed on adherent cells or bacterial bio-films, unlike the prior approaches which 
can be either performed on suspended cells only, or on adherent cells but lacking the resolution 
to interrogate single bacteria. From our images I can also retrieve the cell volume and, thus, 
extract information about the cell density. I found that the volume increase is also exponential 
with the same growth constant as for mass, 0.011 min-1 (see Fig. B.1). It can be seen that on 
average, the volume is linearly proportional to mass, indicating constant average volumetric 
density. These results confirm the commonly accepted fact that, for this simple organism, in 
normal growth conditions, the volume and (because of the constant cell cross section) cell length 
can be used as surrogates for mass [53]. 
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Figure 5.1. SLIM measurements of E. coli growth. (a) Dry mass vs. time for a cell family, growth 
curves for each cell are indicated by the colored circles on the images. The inset shows the histogram of 
the dry mass noise associated with the background of the same projected area as the average cell 
(standard deviation =1.9 fg is shown). The blue line is a fixed cell measurement, with standard deviation 
of 19.6 fg. Markers indicate raw data and solid lines indicate averaged data. (b) Growth rate vs. Mass of 
20 cells measured in the same manner, faint circles indicate single data points from individual cell growth 
curves, dark squares show the average and the dashed line is a linear fit through the averaged data; the 
slope of this line, 0.011 min-1, is a measure of the average growth constant for this population. The linear 
relationship between the growth rate and mass indicates that on average, E. coli cells exhibit exponential 
growth behavior. Images show single cell dry mass density maps at the indicated time points (in min.) and 
the white scale bar is 2 µm. 
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5.2 Cell Cycle Dependency 
Next I investigated the cell growth behavior in mammalian cells. In order to test the ability of 
SLIM to study growth in large populations of mammalian cells over more than a cell cycle, we 
imaged continuously for a two-day period, a 3.2 x 2.4 mm2 field of view of a U2OS 
synchronized cell culture (Fig. 5.2). It is important to note here that for bigger cells it is 
important to select the correct objective to ensure that the integral phase through the entire cell 
thickness is measured; for more details on this measurement refer to Appendixes A and B. Figure 
5.2 shows the results in terms of single cell and ensemble growth curves. The results show that 
the mean cell mass evolves synchronously in time with the total mass of the entire population 
during the duration of a (mean) cell cycle, i.e. 22-26 hours, after which it levels off. This 
indicates that after one cell cycle, the culture loses synchrony and the single cell mass is limited 
by mitosis. This measurement highlights the problems of using a synchronized population for 
cell cycle studies, and reiterates the need for measuring single cells through an entire cell cycle 
in an asynchronous culture. To the best of my knowledge, this type of study, on such broad 
spatial and temporal scales, is impossible using any other existing method, but feasible by SLIM, 
as described below. 
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Figure 5.2. SLIM measurement of synchronized U2OS cell culture over more than 2 days. Black: 
dry mass vs. time for a synchronized cell population over a 3.2x2.4 mm2 field of view obtained by 
montaging 8x8 microscope images. (10X objective, NA=0.3) Red: cell mean dry mass vs. time. Images 
show the field of view at 4 and 45 hrs respectively, horizontal edge of image is 2.4 mm.  
 
 
0 10 20 30 40 50
0
3000
6000
9000
12000
15000
18000
0
15
30
45
60
75
90
0 10 20 30 40 50
To
ta
l D
ry
 M
as
s 
[p
g]
M
e
an
 C
e
ll 
D
ry
 M
as
s 
[p
g]
Time [hrs]
4 hrs
45 Hours
82 
 
To study single cell growth in an asynchronous culture and obtain information about cell 
cycle-dependent growth, I used SLIM in combination with epi-fluorescence imaging. Note that 
because it interfaces with an existing microscope, SLIM shares the same optical path with all the 
other channels of the microscope including fluorescence. I imaged YFP-PCNA (Yellow 
Fluorescent Protein - Proliferating Cell Nuclear Antigen) human osteosarcoma (U2OS) cells, 
stably expressing YFP-PCNA, which enabled me to monitor PCNA activity and thus progression 
through S-phase via the fluorescence channel (Fig. B.2). This activity is greatest during the DNA 
synthesis of the cell cycle and is observed in the localization of the fluorescence signal (its 
granular appearance), which reveals the S-phase of the cell cycle (Fig. 5.3a-b). This marker has 
been used extensively in the past to study cell cycle and replication dynamics (see for example 
[155-157]). Using the fluorescence signal as one marker and the onset of mitosis as the second, it 
is possible to study cell growth in each phase of the cell cycle separately (Fig. B.2). We 
measured a culture of U2OS cells for 51 hours, scanning a 1.2 × 0.9 mm2 area every 15 minutes 
and acquiring fluorescence data every 60 minutes as described in detail in the Appendix A. 
Although a reminiscent halo effect is noticeable in the SLIM images, this does not affect our 
growth measurements if it is thresholded (Fig. B.6 and B.7). In order to avoid cell damage due to 
UV exposure, we minimized exposure time and power by using a highly sensitive EM-CCD as 
discussed in the materials and methods.  The consistent growth of the cells and the expected 24 
hour cell cycle [158] is a testament to the overall health of the culture.  Figure 5.3c shows typical 
growth curves measured from a single cell as it divides into two cells and then its daughters into 
four. This ability to differentiate between two daughter cells growing very close together, and to 
measure their dry mass independently, is a major advantage of SLIM over other methods, 
including micro-resonators, where such measurements are currently impossible to perform. As a 
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control, I measured a fixed cell under the same conditions and found a standard deviation 1.02 
pg, which is well within the acceptable error range. This error is larger than in the case of the E. 
coli measurements because the debris that exists in the mammalian cell culture contributes to the 
measurement noise. This debris is naturally occurring from cellular processes and can 
occasionally be observed passing through the field of view. 
 
Figure 5.3. SLIM measurement of U2OS growth over 2 days. (a) Dry Mass Density Maps of a single 
U2OS cell over its entire cycle at the times indicated; yellow scale bar is 25 m, color bar indicates dry 
mass density in pg/m2. (b) Simultaneously acquired GFP fluorescence images indicating PCNA activity; 
the distinct GFP signal during S phase and the morphological changes during Mitosis allow for 
determination of the cell cycle phase. (c) Dry mass vs. time for a cell family (i.e 1->2->4 cells); the two 
different daughter cell lineages are differentiated by the filled and empty markers; only one daughter cell 
from each parent is shown for clarity. Different colors indicate the cell cycle as reported by the GFP-
PCNA fluorescence. The dotted black line shows measurements from a fixed cell, which has a standard 
deviation of 1.02 pg. 
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The data shows that U2OS cells are typically successful in doubling their mass by the end 
of G2 and that the daughter cells are typically half of the mass of their parents’ doubled mass 
following mitosis. One unexpected observation is that the mass continues to increase during 
mitosis (Fig. B.3). However, after this increase, upon completing cytokinesis, the two daughter 
cells decrease in mass and begin G1 at exactly half the mass of their parent at G2, which is the 
generally accepted behavior [52]. See Appendix B. and Fig. B.3 for more details on mitosis. 
Due to the cell cycle phase discrimination provided by the YFP-PCNA, I can numerically 
synchronize the population a posteriori (Fig. 5.4a). In order to perform this numerical 
synchronization, I measured the average time of each cell cycle phase and then all the growth 
curves are re-sampled to fit the respective time windows. The dotted lines in Fig. 5.4a show the 
results for individual cells and the solid lines indicate the ensemble-averaged data. Although this 
average is performed on a limited number of cells, clear differences in the growth behavior 
during the three cell cycle phases can be observed. Figure 5.4b illustrates the differences in the 
growth rate between the G1, S and G2 phases of the cell cycle. It can be seen that during G2, 
U2OS cells exhibit a mass-dependent growth rate that is approximately linear and thus indicates 
an exponential growth pattern. The large standard deviation is to be expected from a small 
population set growing under heterogeneous conditions in terms of cell confluence. I anticipate 
that the interaction of a cell with its neighbors must play a role in cell growth and plan to study 
this aspect with future experiments. Even though further studies are required in order to make 
universal statements regarding mammalian cell growth, to my knowledge this is the first time 
that cell cycle dependent mass measurements have been performed.  
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Figure 5.4. (a) A posteriori synchronization combination of PCNA stain for S-Phase 
determination and the visual determination of the onset of mitosis allows for the study of cell growth 
dependence on cell cycle phase, in an asynchronous culture. The figure shows G1, S and G2 dependent 
mass growth as indicated by color; the cycles of the individual cells were aligned as described above; the 
x-axis indicates the average time spent in the respective cell cycle phase by all. Open circles indicate 
single cells data and solid lines indicate ensemble averages by cell cycle phase. It can clearly be seen that 
the cell growth is dependent on both the cell cycle phase and the current mass of the cell. (b) Dry Mass 
Growth Rate vs. Dry Mass for the ensemble averages; it can be seen that G2 exhibits a distinct 
exponential growth rate compared to the relatively low growth measured in G1 and S phases. 
a
b
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5.3 Cell Growth and Motility 
Since SLIM provides both imaging and mass measurements simultaneously, it is possible 
to use it to study the effects of spatio-temporal interactions on cell growth, an ability that is not 
shared by any other dry mass measurement technology. This ability was demonstrated by 
measuring the motility of single cell in conjunction with dry mass [159]. As mentioned above, 
the fundamental processes of developmental biology are differentiation, growth and 
morphogenesis. Morphogenesis (beginning of shape) is the process that organizes the 
development spatially and temporally to provide a complex and functional three-dimensional 
structure. To achieve morphogenesis, cell motility is crucial for positioning in space and time 
before undergoing growth or differentiation. Thus to truly understand a proliferating and 
developing cellular system it is necessary to measure both growth and motility. Such a 
measurement can be achieved with no extra effort using SLIM due to its imaging nature.  
Drosophilia Schneider S2 cells were transferred onto a glass bottom dish coated with poly-L-
lysine (PLL) and the sample was scanned every 10 minutes for a total of 47 hours.  PLL 
promotes cell adhesion through electrostatic interactions and thus inhibits cell motility. The cells 
were analyzed using image segmentation as described above; in addition to the mass and 
morphology, the centroid position of each cell at each time point was also recorded. The centroid 
positions were then used to calculate the mean square displacement (MSD) as:  
 
   
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2 2
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   (5.1) 
where ( ) ( )t t r r  is the mean distance travelled by the cell over the time interval  and angular 
brackets denote time averaging. This MSD analysis allows for evaluation of how PLL affects 
cell growth over time. It was found that the cell motility increases with each generation (Fig. 
, 
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5.5a) and that the average growth rate increases with the increase in motility (Fig. 5.5b). In 
addition to the single cell analysis, entire cell clusters were also measured to determine the bulk 
growth properties of S2 cells. Figure 5.5c shows the growth of the clusters in the 3rd and 4th 
generations once the cells are becoming non-adherent. By studying the relationship between a 
MSD and growth rate it was shown that S2 cells do not grow normally when attached to PLL 
substrate. However, the effects of the PLL wear off by the 3rd generation of cells, after which the 
cells exhibit normal growth trends as quantified by the measurements on cell clusters.  
 The results on the various cell types discussed above establish that SLIM provides 
significant advantages over existing cell mass measurement systems: (1) SLIM can perform 
parallel growth measurements on an ensemble of individual cells simultaneously; (2) spatial and 
temporal correlations, such as cell–cell interactions, can be explored on large scales; (3) in 
combination with ﬂuorescence, speciﬁc chemical processes may be probed simultaneously; (4) 
the environment is fully biocompatible and identical to widely used equipment; (5) the imaging 
nature of SLIM offers the ability to directly monitor cells and their surroundings, elucidating the 
nature of any artifacts and providing morphological information simultaneously; (6) a lineage 
study is possible, i.e., a cell and its progeny may be followed; and (7) measurements can be 
performed on cells ranging from bacteria to mammalian cells [13].  
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Figure 5.5 Growth rate and motility. (a) Semilogarithmic plot MSD vs. time for all the individual cells 
tracked. It can be seen that the MSD increases by 3-4 orders of magnitude between the 1st and 4th 
generations. (b) Semilogarithmic plot of the maximum MSD vs. the approximated linear growth rate for 
each cell. (c) Dry mass vs. time for cell clusters in the 3rd and 4th generations. Each colored time series 
corresponds to a single cluster, the solid black line is the average exponential fit for each cluster, with the 
average time constant, τ, shown for each fit. 
5.4 Discussion 
Although population level measurements on various cell types reveal exponential or linear 
growth patterns, we can expect large variability in results from different cell types. My 
experiments on E. coli show that, on average, the cells follow an exponential pattern although 
there is large variation among single cells in the same population. These types of variations are 
expected from a biological system and are of scientific interest in themselves; by studying the 
variations in the growth patterns of single cells under varying conditions we may help elucidate 
some of the underlying regulatory processes. Since SLIM is an imaging technique we may also 
simultaneously calculate the volume of regularly shaped cells such as E. coli. This allows us to 
explore questions of cell density and morphology and their roles in mass regulation. For E. coli 
we found that the density is relatively constant, which is consistent with the exponential growth 
model for this organism [143]. SLIM is also a powerful tool to study the relationship of cell 
cycle stage, growth and mass measurement in complex mammalian cells.   
 By taking advantage of the ability of SLIM to be implemented as an add-on to a 
commercial microscope, we can utilize all other available imaging channels. By combining 
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SLIM with fluorescence it is possible to combine the quantitative nature of interferometry with 
the specificity provided by fluorescent molecular probes. In conclusion, the results presented 
here establish that SLIM provides a number of advances with respect to existing methods for 
quantifying cell growth: (i) SLIM can perform parallel growth measurements on an ensemble of 
individual cells simultaneously; (ii) spatial and temporal correlations, such as cell-cell 
interactions can be explored on large scales; (iii) in combination with fluorescence, specific 
chemical processes may be probed simultaneously; (iv) the environment is fully biocompatible 
and identical to widely used equipment; (v) the imaging nature of SLIM offers the ability to 
directly monitor cells and their surroundings, elucidating the nature of any artifacts and 
providing morphological information simultaneously (vi) a lineage study is possible, i.e. a cell 
and its progeny may be followed; and (vii) measurements can be performed on cells ranging 
from bacteria to mammalian cells. 
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CHAPTER 6. BREAST CANCER GROWTH KINETICS* 
“Throughout the centuries, the sufferers of this disease have been the subject of almost every 
conceivable form of experimentation. The fields and forests, the apothecary shop and temple 
have been ransacked for some successful means of relief from the intractable malady. Hardly 
any animal had escaped making its contribution to hide or hair, tooth or toenail, thymus or 
thyroid, liver or spleen, in the vain search for a means of relief”-W. S. Bainbridge[160] 
The history of cancer treatment [161] has witnessed a tragically slow progression from 
extreme disfiguring surgeries (for example super-radical mastectomies) [162], to bringing 
patients to the brink of death with chemotherapy treatments [163], to our current finer 
understanding of the fundamental molecular and genetic basis [161, 164] of the disease. For 
example, breast cancer, which accounts for 30% of all diagnosed cases and for 14% of all cancer 
related deaths in women [165] has been subject to a dramatic decrease (7%) in incidence from 
2002 to 2003. This  decrease can be directly attributed to a better understanding of the link 
between estrogen and the growth of breast cancer which was first established more than a 
century ago [166]. This knowledge led to the development of a class of agents that directly 
modulate the estrogen receptor (ER) and are now the linchpin of treatment and prevention in ER 
positive patients [167]. Despite our improved understanding of cancer at the molecular level, 
screening methods for anti-cancer compounds have remained essentially unchanged for decades.  
In the 1950s the realization of the benefits of chemotherapy resulted in the 
commencement of large scale drug development programs at both research institutes and 
pharmaceutical companies. Initially, murine models and transplantable tumors were adopted by 
the National Cancer Institute (NCI) as their primary screen and by 1974 over 40,000 compounds 
                                                            
* The work presented in this chapter was performed in collaboration with Prof. Benita S. Katzenellenbogen and Dr. 
Anna Bergamaschi in the school of Molecular and Cellular Biology at the University of Illinois at Urbana-
Champaign. 
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were being tested annually [163, 168]. In1990, NCI adopted a panel of 59 human cancer cell 
lines grown in vitro as its primary assay [169, 170]. To measure cell growth and viability in this 
new screen, metabolic assays were developed and explored many of which are still in use today 
[169, 171-175].  
One form of these metabolic assays is based on the reduction of a colorless terazolium salt to 
yield a colored formozan proportional to the number of viable cells. Although these assays are 
useful for measuring the overall cytotoxic effectiveness of  a compound, large numbers of cells 
have to be used to avoid incorrect conclusions from effects such as variable doubling times 
[169]. Non-tetrazolium based assays were also developed that are based on dyes that bind 
electrostatically to basic amino acids [174] and the measured signal is thus linear with the cell 
count.  Despite the practical difficulties involved, one such reagent known as sulforhodamine B 
(SRB) was eventually adopted for routine screenings. However, both assay types provide indirect 
measurements of growth; the tetrazolium based assays measure metabolic activity whereas the 
SRB assay essentially measures total protein concentration. Both methods rely on using large 
numbers of cells, only provide bulk measurements and are unable to measure time-dependent 
responses to drugs at the cellular level. Typically, growth assay data is supplemented with 
fluorescence activated cell sorting (FACS) experiments to provide additional statistical 
information, study gene expression, and study cell cycle progression. For FACS experiments, 
cells are removed from normal culture conditions, clusters are separated, and cells are often 
subjected to various other treatments and labelling procedures. This drastic change in 
environment is undesirable and its effects on the population phenotype are unknown. 
It is becoming increasingly clear that to truly understand the nature of cancer cell 
proliferation and to develop personalized adjuvant therapies to treat it, quantitative information 
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on cell growth and morphology is required at the single-cell level. The ideal drug screen would 
be sensitive enough to rapidly assess the response of a small number of cells to a variety of 
potential therapies in order to directly evaluate the response of a patient or the efficacy of a 
particular drug. The major reason such a technology has not been developed is due to the 
practical difficulties in measuring cell growth at the single-cell level. Here we show that spatial 
light interference microscopy (SLIM) can be used to address this technological gap [12]. SLIM 
has femtogram level sensitivity to changes in dry mass and can simultaneously provide this 
information at both the single-cell and population level [13].  SLIM can also be combined with 
fluorescence microscopy to measure cell cycle dependent growth [13]. In this work we use the 
MCF-7 cell line as a model system to demonstrate that SLIM can be used as a highly sensitive 
drug proliferation assay. 
The MCF-7 cell line is a widely used model for studying hormonal influence on breast 
cancer growth as it is the first ER positive  [176, 177] and estrogen responsive [178, 179] human 
breast cancer cell line to be developed. We measured the growth of MCF-7 cell clusters in 
standard cell culture media (Veh) under the influence of estradiol (E2), the predominant form of 
estrogen during reproductive years, and ICI, 182, 780 [180], a complete antagonist of the ER 
used to treat metastatic breast in postmenopausal women. The results shown here establish that 
in addition to being a superior proliferation assay, SLIM also provides biologically relevant 
information at the cellular and cluster level that is not accessible through other methods. Such 
measurements, in combination with existing molecular assays, have the potential to improve 
drug design and characterization and also to bridge the connection between our molecular 
understanding of cancer and its effects on cell growth.  
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6.1 Effects of Estrogen on MCF-7 Growth Kinetics 
 
Figure 6.1. Measuring cancer cell proliferation using SLIM dry mass measurements. (a) Schematic 
of experimental setup. A fully automated commercial phase contrast microscope equipped with stage top 
incubation control and x, y, z scanning capabilities was used to scan a 1.5 mm x 1.2 mm area in each well 
of a 2-well slide every 30 minutes. The components in the dotted line comprise the SLIM add-on module: 
Fourier Lens 1 (FL1) projects the pupil plane of the phase contrast microscope onto a Liquid Crystal 
Phase Modulator (LCPM) which provides control over the phase delay between the scattered and un-
scattered light; Fourier Lens 2 projects the phase modulated image onto a CCD. All components of the 
instrument were synchronized using the CPU. (b) Representative images of a scanned field of view in one 
of the chambers at 0 hours and 94 hours, the area in the dashed yellow line is enlarged and shown at each 
time point (yellow scale bar is 50 microns). (c) Average normalized surface area for clusters in each 
group in the labelled time periods. (d) Average normalized mass for clusters in each group in the labelled 
time periods. (c-d) Square markers indicate mean, center line is median, top of box is 25th percentile line, 
bottom is 75th percentile line, whiskers indicate 5th and 95th percentiles, significance was tested using an 
un-paired t-test, o: p>0.05, *: p<0.05, **: p<0.01, ***: p<0.001. (e) WST-1 proliferation assay 
measurement at 72 hours.   
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Measurements were performed in three conditions (see Appendix A for more details on 
cell culture and treatment): first typical cell growth media as the control vehicle (Veh), second 
with 10 nM Estradiol (E2), and finally with 1 µM ICI + 10 nM E2 (E2+ICI). For the E2+ICI 
treatment, cells were grown under E2 conditions for 10 hours before ICI was added. The 10 hour 
point was chosen to administer the drug since that is the earliest point at which a significant 
difference between the growth rates of Veh and E2 populations was observed (Fig. B.8). In each 
experiment a two-well slide was used, with one well under the Veh or E2+ICI treatments and the 
other under the E2 treatment. A 1.55 x 1.16 mm2 area of each well was scanned every 30 
minutes using a commercial phase contrast microscope equipped with a SLIM add-on module. 
As shown in Fig. B.10 the sensitivity of the mass measurement is on the order of picograms for 
all experiments. 
A schematic of the instrument and representative SLIM images from one well are shown 
in Fig. 6.1 a and b respectively. SLIM maintains subcellular resolution (Fig. 6.1b) over a large 
area, by scanning each chamber in a mosaic pattern (for more details on the measurement refer to 
Appendix A). From the large mosaic images, the edges of individual clusters (composed of 2-3 
cells at t=0 hours) were traced at each time point and the surface area and total dry mass were 
measured. In this manner we can analyze both the overall growth trends of each group and the 
heterogeneity at the cluster level within each population. It should be noted that this type of 
measurement is currently impossible to perform with any existing proliferation assay.  
First, we establish the capabilities of SLIM as a proliferation assay by measuring the 
effects of estrogen on the relative changes in growth, which is qualitatively similar to the 
information provided by conventional assays. The quantities of interest here are the relative 
amounts of growth in size and mass, not the absolute values. To perform this analysis, the mass 
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and surface area of each cluster is normalized relative to its initial size (M(t)/M(t=0) and 
Area(t)/Area(t=0)). The normalized area and mass for all analyzed clusters were separated into 
15 hour bins as shown in Figs. 6.1c and d (see Fig. B.9 for data at all time points and clusters).  
It can be seen that although there is not a significant difference in the normalized area at 
every time point, the differences in the normalized mass are detectable throughout the 
measurement period. This highlights the importance of measuring mass rather than simply the 
size of a cluster. It can also be seen that the ICI treatment takes effect rapidly as the E2 group 
exhibits greater relative growth in the mass within 30 hours. A difference between the E2+ICI 
and control group can be detected by 60 hours. These results establish that SLIM can detect the 
effects of estrogen on proliferation rate (size and mass growth) earlier than can be detected with 
colorimetric assays conducted on large samples. Furthermore, current proliferation assays rely on 
using a large number of cells whereas the SLIM measurements were performed at the individual 
cluster level. 
For comparison, measurements from a WST-1 assay taken after 72 hours of treatment are 
shown in Fig. 6.1e.  It can be seen that there is a good qualitative agreement between the WST-1 
data, which indirectly measures proliferation rate, and the normalized area measurements after 
75 hours. However, the normalized mass is higher in the control than the E2+ICI group after 60 
hours.  These differences are likely due to the fact that the WST-1 assay simply measures the 
reduction of a tetrazolium dye outside the cell. Although the level of this reduction is related to 
the metabolic activity of the cells and reflects the number of viable cells in the population, it is 
not a direct measurement of cellular mass or size. Furthermore, such assays are restricted to 
providing one number for a bulk population and provide no practical way to study the 
heterogeneity in the population.  
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 In addition to providing a quantitative understanding of how various treatments affect 
relative changes in size and mass, SLIM can also measure changes in the growth rate of small 
cell clusters as a function of time or size. Measuring the growth rate with high sensitivity is more 
informative than simply measuring relative changes in mass as it provides an understanding of 
when treatments begin to take effect and how long the effects persist. Dry mass density maps of 
typical clusters from each group over time are shown in Fig. 6.2a. Figure 6.2b shows the growth 
rate of clusters in each group vs. time. A significant difference in the growth rate between all 
three groups can be detected as early as 15 hours (5 hours after ICI treatment was administered), 
which is 15 hours earlier than the detectable change in both the area and mass. Furthermore, 
although the normalized mass is greater for the E2+ICI group than the control up to 60 hours, the 
growth rate of the control exceeds the E2+ICI group by 45 hours. It can also be seen that 
although clusters in the E2 group achieve much larger relative masses and areas than the control 
there is no significant difference in the growth rates between the two groups after 90 hours.  
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Figure 6.2. Cluster growth rate analysis. (a) Dry mass density maps of representative clusters from 
each group at every 22 hours. The colors indicate the dry mass density at each pixel as shown on the color 
bar. The yellow scale bar is 50 microns. Note that in the E2 + ICI group, ICI was added to each sample at 
10 hours. (b) Cluster growth rate in each group in the shown time period. (c) Cluster growth rate in each 
group as a function of normalized mass. Solid lines are shown as a guide to the eye to determine how the 
growth rate is changing as a function of mass growth. (b-c) Square markers indicate mean, center line is 
median, top of box is 25th percentile line, bottom is 75th percentile line, whiskers indicate 5th and 95th 
percentiles, significance was tested using an un-paired t-test, o: p>0.05, *: p<0.05, **: p<0.01, ***: 
p<0.001. 
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By plotting the growth rate as a function of the normalized mass (Fig. 6.2c), the growth 
trend (exponential or linear) of the groups can be determined. It can be seen that the mean 
growth rate of clusters in the E2 and Veh groups continues to increase until a 4-fold increase in 
mass is achieved, after which the growth rate is either stable or decreases. This trend implies that 
for approximately two mass doublings both groups exhibit exponential growth, after which the 
growth is linear. In contrast, the E2+ICI group exhibits exponential growth until a 2-fold increase 
in mass is achieved, after which the growth is linear. It is important to note here that a doubling 
in the mass does not necessarily correspond to a complete cell cycle as both estrogen and ICI are 
known to result in changes in how a cell progresses through the cell cycle; i.e. the doubling time 
and size and division both may be affected.  
To determine how changes at the single-cell level contribute to the measurable changes in 
relative size, mass, and growth rates, we measured the doubling time and percent change in mean 
cell size for individual cells that compose the clusters (Fig. 6.3). The doubling time is calculated 
simply as  2t / log ( ) / (0)f cell f cellN t N  , where tf is the last time point, t0 is the initial time point 
and Ncell (t) is the cell count at time t. The doubling times for the E2 group were found to be 
significantly lower than both the Veh and E2+ICI groups (Fig. 6.3a). This data shows that 
estradiol causes cells to divide at almost twice the rate as the control group and that treatment 
with ICI almost completely reverses this effect. This data confirms the suspicion that estrogens 
result in cells “rushing” through the cell cycle, a well-established hallmark of a fast growing 
tumor. It should be noted that the increase in the doubling time following ICI treatment does not 
imply that the cell cycle is returned to normal conditions and could result from the cells spending 
a larger amount of time in a specific phase of the cell cycle.  
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Figure 6.3. Estrogen modulated changes in proliferation kinetics. (a) Doubling time in each group; 
the mean doubling time is reduced by 12 hours in the E2 group compared to the Veh and E2 + ICI groups, 
indicating that adding ICI returns the doubling time to control levels. (b) Percent change in the mean cell 
mass over the measurement period for each group. A significant decrease in the cell mass is observed in 
both the E2 and E2+ICI groups compared to the control. (c) Measured doubling time vs. change in mean 
cell mass for each cluster that was measured; these two parameters can be used to separate the three 
groups completely and can serve as a growth signature.  
The change in mean cell mass over time was calculated by dividing the total mass of each 
cluster by the number of cells in the cluster. Figure 6.3b shows the percent change in the mean 
cell mass between the initial and final time points for each cluster. The data shows a significant 
decrease in the mean cell mass over time in the E2 and E2+ICI cells as compared to the control. 
This decrease in cell mass and doubling time shows that compared to the control, estrogen results 
in smaller, faster dividing cells, and that adding ICI results in longer doubling times along with 
smaller cells. The smaller cells in the E2+ICI groups imply that although the doubling time has 
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returned to control levels, ICI is affecting the cells’ metabolic activity and ability to grow 
normally. As shown in Fig 6.3c, the doubling time and change in mean cell mass provide a 
reliable “growth signature” for each group and suggest that the levels of expression of the 
estrogen receptor or presence of an ER modulator may be assessed simply by examining these 
two parameters. To the best our knowledge, these are the first measurements that elucidate how 
estrogen affects MCF-7 growth kinetics at the cellular level. 
6.2 Discussion 
The results shown here establish that SLIM measurements of dry mass density can be used as 
highly sensitive proliferation assays. The main advantages over existing techniques are that 
SLIM can detect changes in growth kinetics on fewer cells, in less time, and can be used to study 
differences within a population rather than just providing a number for the bulk growth of a 
culture. As a comparison, the WST-1 assay works with cell numbers in 103-105 range [181] 
whereas SLIM is sensitive to changes in the proliferation of even a single cell. Furthermore, 
SLIM provides the capability to analyze the growth rate of individual cells and clusters as a 
function of their mass, providing insight on the mechanism of growth regulation (e.g., whether a 
size or age checkpoint is being utilized). This information is inaccessible to any existing 
proliferation assay. Although we have demonstrated these capabilities on just one cell type and 
growth modulation scheme, this system can be readily used to measure any cell type and 
treatment.  
Our results also demonstrate that measuring growth at the cellular and cluster level not 
only provides advantages in terms of improved sensitivity and reduced sample sizes, but also 
provides additional information that is not accessible by existing methods. In particular, we show 
that under the influence of E2, MCF-7 cells divide faster and achieve lower masses, resulting in 
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an increased number of cells that are on average smaller. Due to the reduced doubling time, this 
still results in an overall increase in total mass for E2 when compared to the control group. For 
cells grown in E2 and subsequently treated with ICI, the doubling times returned to those found 
in the control; however, the reduction in cell size is still greater than in the control group.  
The effects of E2 and anti-estrogens on cell-cycle progression have previously been 
studied in detail [182-185]. Both rapid and transient effects have been observed due to functional 
activity in both the nucleus (genomic effects) and cytosol (non-genomic effects) [186]. The 
transient effects on growth are clearly observable in our data as the differences in the growth rate 
between the E2 and Veh are observable after 10 hours (Fig. B.8). After the addition of ICI at this 
time, the differences in growth rate between the E2 and E2+ICI group diverge slowly over time 
(Fig. 6.2a).  The transient effects of E2+ICI are also manifested in how the growth rate changes 
as a function of increase in cell size (Fig. 6.2b); a clear break in the growth rate can be observed 
when the ICI clusters approximately double in size.  
 Estrogens are known to activate transduction cascades which regulate several genes –
both positively and negatively—that play key roles in cell proliferation [182, 184, 187-190]. It 
has also been shown that estrogens cause non-cycling cells (G0 phase) to enter the cell cycle and 
to rapidly progress through the G1 to the S phase [182, 184, 185]. This rapid progression through 
the cell cycle accounts for both the decreased doubling time and reduction in average cell mass 
observed in the E2 group (Fig. 6.3). The greater variance in the growth data for E2 clusters is 
also likely caused by progressing haphazardly through the cell cycle, resulting in increased 
mutations and lack of size regulation.  On the other hand, ICI a pure-antagonist, has been shown 
to significantly block MCF-7 cells in the G1 phase. This inhibitory action on the progression 
through G1 is manifested in the increased doubling time of the E2+ICI group when compared to 
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the E2 group. ICI also affects transcription of several genes responsible for growth in all phases 
of the cell cycle. The down-regulation of genes known to be responsible for proliferation, in 
combination with the increased time spent in G1, is likely responsible for the reduction in the 
cell size observed in the E2+ICI group [184].  
As in the case of the estrogen receptor, all cellular proliferation is ultimately controlled 
through the modulation of regulatory signaling cascades by growth factors; measuring growth at 
the cellular level has the potential to bridge the gap between the molecular understanding of 
cancer growth and the actual tumor growth.  Thus it is of great interest is to combine these 
growth measurements with fluorescence markers for cell cycle phase (as was done previously for 
U2OS cells [13]) or other proteins known to play key roles in regulating proliferation. 
Measurement of changes in the growth kinetics as a function of the cell cycle, or more 
specifically gene activation, will allow for better understanding of the particular action of a 
compound/drug on cell cycle progression.  
In summary, we have demonstrated the potential of SLIM to be used as a highly sensitive 
proliferation assay for drug screening applications. Although we have focused on a specific 
model system here, the experimental setup does not need to be altered to measure other cell types 
and treatments. In addition to measuring growth kinetics, SLIM also simultaneously provides 
information on cellular morphology and motility [159], and can also be readily combined with 
other microscopy modalities. A subject of future study will be to understand and characterize the 
morphological differences that arise as a result of modulating the ER. The biological insights 
provided by SLIM measurements in combination with other molecular assays will undoubtedly 
improve our understanding of cancer cell growth in general, and have the potential to lead to 
improvements in the drug design and characterization process.   
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CHAPTER 7. NEURAL NETWORK FORMATION* 
The emergence of network self-organization in the developing central nervous system is a highly 
complex and insufficiently understood process [191]. Neurons use a diverse variety of internal 
and external guidance cues to direct their organization into functional units. In a developed 
nervous system the spatial arrangement (i.e., location) of individual neurons is known to be 
closely linked to specific functional activity, a phenomenon which has been studied extensively 
in the visual cortex [192-194].  This spatial arrangement ultimately determines how neurons 
connect to each other to form neural circuits. Once a connection is made, neurons communicate 
with each other using a complex system of neurotransmitters, neurotrophins, peptides, and 
cytokines [191, 195-203]. The spatiotemporal interaction among individual neurons within a 
network is the basis of all functional activity in the nervous system and higher level cognitive 
functions such as sensory perception, memory, and learning. Thus, understanding the formation, 
stabilization, and behavior of neural networks is a key area of study in neuroscience, 
developmental and synthetic biology, and regenerative medicine. In order to gain insight into 
how functional neural networks form and develop, it is necessary to quantify how individual 
neurons grow and spatially organize with respect to each other, and to understand the dynamics 
of how mass is transported within connected units, preferably through longitudinal 
measurements within the same neural cultures.  
Neural network formation has been studied by various models, ranging from whole brain 
animal studies [199, 204] to in vitro dissociated neuron cultures [201, 205]. However, there are 
many limitations to each of these models. For example, the analysis of in vitro neuron cultures is 
limited by the relative lack of data that can be obtained from conventional live-cell imaging 
                                                            
*This work was performed in collaboration with Prof. Steve Stive and Dr. Anirban Majumder at University of 
Georgia, Athens and Prof. Martha Gillette and Chris Liu in the Department of Cell and Developmental Biology. 
Ryan Tapping and Mike Xiang contributed image analysis. 
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techniques such as phase-contrast or differential interference contrast (DIC), which only report 
on morphology and must be coupled with other methods such as fluorescence to provide 
functional information.  Fluorescence imaging techniques have been used to image vesicle 
transport and synapse formation [206]. More recently, fluorescent voltage-sensors have been 
used to optically measure electrical activity [207, 208]. However, the limitations inherent to 
fluorophores, such as photo-bleaching and photo-toxicity, do not allow for continuous 
monitoring of these processes during dynamic neural-network function on the relevant time 
scales of days to weeks.  
Recent advances in micro-fabrication methods have led to several innovative approaches 
to study in vitro neural cultures. For example, multi-electrode arrays have been extensively used 
for measuring electrical activity of neural cultures [209, 210]. However, due to their limited 
spatial resolution they only provide an incomplete electrophysiological picture of the system. 
Micro-patterning methods have enabled the design of spatial order that generally mimics what is 
found in live neurons [201, 211-213]. Furthermore, recently developed microfluidic approaches 
are amenable to rapid, high content analysis of various cell properties [191, 200, 202, 214-218]. 
Such methods provide important information on how cells behave when spatial cues are 
provided but are inherently limited in their capabilities to address how spatial order naturally 
emerges in a culture.  
Little is known about the neuron culture in terms of spatial organization, energy use, and 
mass transport. Our current understanding of these phenomena is limited by the lack of available 
technologies to quantitatively measure a forming neural network at multiple temporal and spatial 
scales, in a high throughput and minimally invasive manner.  In this work we show that by using 
a recently developed optical interferometric technique known as spatial light interference 
105 
 
microscopy (SLIM) [12, 32] we can measure several fundamental properties of the developing 
network on a broad range of spatial (sub-cellular to millimeter) and temporal scales (seconds to 
days) in a completely label-free and non-invasive manner. The results indicate that 
measurements on cell growth, intracellular transport, and scattering structure function are 
quantitative indicators of neural network emergence. 
As described in the previous chapters, SLIM is a quantitative phase imaging (QPI) 
modality which measures the pathlength shift distribution of an optical wave front as it passes 
through a cell [2]. Due to its common-path geometry, broadband illumination, and ability to 
interface with existing phase contrast microscopes, SLIM is a highly sensitive and versatile QPI 
modality [6]. It has been demonstrated that SLIM has spatial and temporal path length 
sensitivities of 0.3 nm and 0.03 nm, respectively [12]. When translated into dry mass this 
sensitivity corresponds to changes on the order of femtograms. In combination with SLIM’s 
multimodal capabilities this has allowed for the measurement of single-cell dry mass growth in a 
cell cycle dependent manner [13]. When this measurement is performed with high temporal 
resolution it can be used to quantify changes in inter- and intra-cellular mass transport 
characteristics. This method is known as Dispersion Phase Spectroscopy (DPS) [42, 64].  While 
the mass growth measurements provide information on the overall metabolic activity of the 
system, DPS reports on whether energy is being used to transport materials in a deterministic 
manner. Our results show that in a developing neural network, changes in the overall growth rate 
and network morphology are intrinsically linked to the mass transport behavior of the system.  
In addition to dry mass growth and transport, the measurement of the complex optical 
field allows for direct measurements of the angular scattering spectrum from the sample [100, 
219-221]. It has recently been shown that despite the complexity of the network formation 
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process in vivo, neurons will self-organize in a non-random manner in vitro without the provision 
of any additional external environmental cues [218], that is, relying only on chemical gradients. 
Previous work on analyzing this organization relied on detecting the location of individual 
neurons in an image and was, thus, time-consuming and prone to error. The angular scattering 
data measured by SLIM allows for monitoring how spatial correlations in the culture evolve over 
time at various spatial scales simultaneously, allowing for a way to quantify organization at all 
spatial scales simultaneously without the need for image segmentation. It has been shown that 
the shape of the angular scattering power spectrum reports on the large scale spatial organization 
of tissue [222] and on the fractal properties of the spatial organization of the clusters and cells 
within the clusters.  Performing this measurement on a developing neuronal network revealed 
that changes in spatial correlations at certain scales are linked to the overall growth behavior of 
the culture.  
The ability to simultaneously measure the metabolism, transport characteristics and 
spatial correlations of an evolving neural network provides a unique and efficient way to 
quantify the behavior of such systems. In this work we show that changes in the trends of these 
fundamental properties are linked temporally and across broad spatial scales. Since all these 
measurements are obtained from the same quantitative phase data using a completely non-
invasive and label-free method, they allow for monitoring the evolution of an in vitro neural 
network in an unprecedented manner. 
7.1 Measuring a Forming Network 
The human embryonic stem-cell-derived neurons used in this study [223, 224] hold 
therapeutic potential [225, 226] and express multiple, well-established neuronal markers, 
including MAP2 [227]. The development of the neuronal network was characterized using 
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several analysis techniques, both to understand the dynamic behavior at the single-cell level and 
to characterize the metabolic activity and spatial organization of the system population. First, the 
system was characterized in terms of the total dry mass of the entire field of view (Fig. 7.1). This 
procedure provides a broad view of the metabolic activity of the culture. Second, mass transport 
in the system was characterized using DPS (Fig. 7.2). Finally, the angular light scattering 
spectrum was calculated at each time point in the 24 hour movie to characterize the spatial 
organization of the culture (Figs. 7.3 and 7.4).  
Dry Mass Growth 
The total dry mass of the 0.87 mm × 1.16 mm area was calculated at each time point (every 10 
minutes), as described in Appendix A. Figure 7.1a shows that the distribution of mass is 
drastically different between 0 hours and 24 hours, changing from compact isolated clusters to a 
highly connected network. After an initial period of growth that lasts 10 hours, the mass growth 
levels off and then begins to decline after 20 hours. The images suggest that the mass increase 
during the first 10 hours is largely caused by the extension of neurites from each cluster; once the 
connections are well established, there is no significant increase in the total dry mass of the 
culture. In terms of the culture’s metabolic activity, this time development indicates a shift from 
using energy to form connections between clusters, to consuming energy for spatial 
reorganization and deterministic transport of materials. This hypothesis is supported by the mass 
transport and scattering measurements reported below. 
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Figure 7.1. Dry mass growth of the human neuronal cell culture. (a) Dry mass density maps acquired 
at 0, 10 and 24 hours. The yellow scale bar corresponds to 200 µm. (b) Total dry mass vs. time of the 
entire field of view. Grey markers are raw data, the solid black line is the average over 1 hour, and the 
error bars show the standard deviation of the averaged data.  The majority of the mass growth occurs 
between 0 and 10 hours, the time during which the cells are extending processes most actively.  
Mass Transport 
To quantify changes in the mass transport characteristics at the single cell and cluster level, DPS 
analysis was performed on the 40×, 0.5 Hz movies taken at t=0  and t=24 hours. Six and 8 
movies were acquired and analyzed at t=0 hours and 24 hours, respectively.  
The data acquired at t=0 hours shows that the mass transport is primarily diffusive. In 
sharp contrast, when the culture is highly connected after maturing for 24 hours, a large amount 
of vesicular transport occurs in the processes that connect the clusters. The dispersion analysis 
shows that the mass transport is dominated by directed motion, which can be attributed to bi-
directional transport  that occurs along defined tracks, facilitated by molecular motors such as 
dynein and kinesin [228, 229]. These results support the hypothesis that, initially, the culture 
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consumes energy primarily to extend processes towards other clusters. After 24 hours, a 
statistically significant increase in the mean advection velocity was found, indicating a shift 
toward deterministic transport of mass. Interestingly, there is no significant change in the mean 
diffusion coefficient. This result indicates that, at small scales where diffusive transport is 
dominant, the overall mass transport is not affected by network formation. The spread of the 
diffusion coefficients is much larger at 24 hours, suggesting that in network formation, local 
transport becomes more inhomogeneous. These mass transport measurements provide a way to 
quickly quantify and characterize the morphological connectivity of a network, which is a 
prerequisite for the emergence of functional activity. 
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Figure 7.2. Mass transport results for the human neuronal cell culture, obtained from analysis of 
dispersion phase spectroscopy (DPS) data. (a) Radial profiles of the dispersion maps calculated from 
high resolution movies acquired at a rate of 0.5 Hz at 0 (red) and 24 (black) hours. Faint lines are the 
profiles from individual movies and the darker lines are the averages calculated from these movies. A 
clear shift from a quadratic to a linear behavior can be seen as indicated by the dashed blue lines. (b) 
Comparison of mean advection velocities obtained from DPS analysis. There is a statistically 
significantly difference between the mean values at 0 hours and 24 hours; indicating a shift from diffusive 
to deterministic transport. (c) Comparison of mean diffusion coefficients obtained from the DPS analysis. 
There is no statistically significantly difference between 0 hours and 24 hours, however, there is an 
increase in the range of the measured values. The whiskers indicate one standard deviation above and 
below the mean (gray dot).  
Angular Scattering 
When measuring mostly transparent, optically thin samples, such as neurons, we can assume that 
the amplitude of the optical field is left unperturbed and that only the phase measured by SLIM 
is altered by the sample. In this case, SLIM provides a measure of the complex optical field, 
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( , )( , ) ( , ) i tU t U t e  rr r , at the sample plane. This field may then be numerically propagated to the 
far-field or scattering plane by simply calculating its spatial Fourier transform [100] as 
2( ) ( ) iqU U e d  
r
q r r , where q is the scattering wave vector. The modulus square of this 
function,
2
( ) ( )P Uq q , is related to the spatial auto-correlation of the measured complex field 
through a Fourier transform, 2 2( ) ( ') ( ') 'iqP e d U U d   
r
q q r r r r , and thus describes the spatial 
correlation of the scattering particles in the sample.  Since the signal is measured and 
reconstructed in the image plane, rather than in the far field as in traditional scattering 
experiments, all the scattering angles that are allowed by the numerical aperture of the 
microscope objective are measured simultaneously. This greatly enhances the sensitivity to 
scattering compared to the traditional approach of goniometric measurements [100].  
Since SLIM is an imaging modality it is possible to connect changes in the scattering 
intensity at certain angles to morphological changes at relevant spatial scales. Figure 7.3a shows 
the scales of features such as the cell body diameter, cluster size and distance. Once the angular 
scattering spectrum is calculated as described above, the intensity is averaged over rings of 
constant scattering angle or scattering wave vector. This radial average, calculated at each time 
point, is shown in Fig. 7.3. The dashed lines in Fig. 7.3b divide the profile plot into different 
spatial scale regions, which are associated with different structures in the culture (see Fig. 7.3a). 
Figure 6.3b shows that, as the culture matures, the profile slope changes in different spatial 
ranges. The greatest changes are observed in spatial scale regions corresponding to the size of the 
clusters (605- 315 µm), the distance between clusters (210-105 µm), and the distance between 
cells (90- 35 µm). Specifically, from 0-24 hours, the power spectrum narrows monotonically, 
which indicates a broadening of spatial correlations. Remarkably, our label-free imaging is able 
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to monitor the temporal evolution of the neuron culture and quantify the enhancement of spatial 
correlations over time. Note that the slopes in spatial ranges corresponding to the size of 
individual soma (30-15 µm) remain constant, which suggests that local morphology remains 
essentially constant.  
 
Figure 7.3. Angular scattering analysis of SLIM images. (a) Dry mass density map of the culture at 24 
hours. Various spatial scales have been labeled to aid in the interpretation of the angular scattering maps. 
(b) Radially averaged profile plots of the angular light scattering map from each time point in the data. 
The plots are color coded such that the color corresponds to the time point shown on the color bar.  The 
dashed lines and corresponding labels indicate the various spatial ranges into which the profiles were 
divided. The slopes in each region change with time, with the greatest changes in slope occurring at the 
spatial scales corresponding to the size of the clusters, the inter cluster distance, and the inter-soma 
distance.  
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In order to evaluate these changes in the slope of the angular scattering profiles 
quantitatively, the profiles were analyzed in the various spatial scale regions indicated by the 
dashed lines of Fig. 7.3b. Each region was then fit to a power law function of the form
( )P q cq . The power of the exponential relationship, α, for each of the spatial ranges vs. time 
resulting from these fits is shown in Fig. 7.4 for each spatial region. Figure 7.4 a-c show that (t) 
exhibits the greatest changes in the 35 mm to 630 mm spatial scale regions. Furthermore, the 
power law behavior associated with the largest spatial scales (Figs. 7.4a, b) exhibits the greatest 
changes after 10 hours, as the larger clusters begin to merge. By contrast, the power law 
behaviors associated with spatial scales corresponding the inter-soma distance (Fig. 7.4 c) and 
the width of individual neurites (Fig. 7.4 f) stabilize after 10 hours. Figures 7.4d and e, which 
correspond to the size of individual soma, suggest that the cellular and subcellular morphology 
remain essentially unchanged. Notably, the changes in spatial correlations and the stabilization of 
the growth rate (Fig. 7.1) occur at approximately the same time. This suggests that there is active 
reorganization of the system once the neurons have already extended neurites to connect to 
neighboring clusters.  
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Figure 7.4. Power law behavior at various spatial scales of the angular scattering profiles. (a) 605- 
315 µm range, corresponding the largest clusters, (b) 210-105 µm, corresponding to smaller clusters and 
inter-cluster distances, (c) 90-35 µm, corresponding to distances between cell soma, (d) 35-15 µm, size of 
individual soma, (e) 15-4 µm, features smaller than the soma, (f) 4-2.5 µm, width of individual processes. 
7.2 Discussion 
In summary I have shown that, using quantitative phase imaging it is possible to characterize 
several fundamental properties of a forming human stem cell derived neuronal network. To my 
knowledge this is the first time that mass growth in a neural culture has been measured and 
linked to changes in transport dynamics and spatial organization. I found two distinct phases in 
the growth rate of the culture, the first of which is marked by mass accumulation and the second 
by a relatively stable total mass. From the imaging data, I identified that the first phase 
corresponds to extension and growth of neurites and that the second phase is characterized by the 
115 
 
aggregation of clusters and spatial reorganization of cells. By performing mass transport analysis 
I determined that there is a significant increase in deterministic transport after 24 hours, 
suggesting that the energy consumption of the culture has shifted from extending neurites to 
transport of materials along these extensions.  Finally, by measuring the angular scattering from 
the culture I quantified the temporal evolution of spatial correlations in the system. Interestingly, 
the data shows that the increase in spatial correlations at the scales of cluster size and inter-
cluster distances is temporally coincident to the shift in growth rate and dominant mode of intra-
cellular transport. This observation suggests that in this system the majority of spatial 
organization occurs after clusters in the network are already well connected.  
The methods and analysis that have been developed and proven here can be applied to a 
variety of studies in neuroscience and beyond, with the potential to transform how basic behavior 
such as growth, spatial organization, and transport are measured and quantified. Since SLIM is 
easily interfaced with existing microscopes it is also possible to incorporate commonly used 
tools to provide external perturbation such as through microelectrode arrays, optical tweezers, 
microfluidics and micropipettes. My analysis provides a practical way to characterize the spatial 
correlations in neural networks at all relevant spatial scales simultaneously. Combining external 
stimulation with the technology demonstrated here, it will be possible to quickly assess the 
effects of various forces on the natural evolution and maturation of a neural culture, opening the 
door to develop novel experimental strategies and, potentially, new therapeutic methods.  The 
linkage of informative SLIM measurements with the in vivo outcomes of the novel transplanted 
cells, such as level of sensory and motor function, will likely expedite efficacy and optimization 
for newly developed neural stem cell therapies.  
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CHAPTER 8. SUMMARY AND OUTLOOK 
Since their inception, the fields of cell biology and microscopy have been progressing hand in 
hand. Unfortunately, as far as most biologists are concerned, the state of the art for intrinsic 
contrast imaging remains Zernike’s phase contrast or DIC, with the majority now using 
fluorescence imaging to meet their needs. In this thesis I have demonstrated that quantitative 
phase imaging not only provides superior contrast but also provides unprecedented information 
about fundamental properties of a biological system. In particular, by measuring a dry mass 
density map important insight is gained into the basic behavior of cells. It is not being suggested 
that QPI systems replace fluorescence imaging, but rather that they add complementary 
information and provide a more detailed and biologically relevant picture of the phenomena 
being studied. In some cases, such as in measuring single cell mass, the capabilities of QPI are 
unique and provide the capability to ask questions and develop technologies which were 
previously unimaginable. It is clear that in the near future QPI methods will play a significant 
role in advancing biomedical imaging and will aid in the transformation of biology from an 
empirical to a quantitative science. In this chapter I will briefly summarize the results presented 
in this thesis and also discuss potential future directions. 
Over the past decade QPI has been well established as an important tool for quantitative 
biology. In Chapter 2, I described the general principles for building QPI instruments and 
described the advantages and disadvantages of various approaches. These trade-offs between 
various optical configurations and reconstruction methods have been thoroughly explored and 
characterized. Furthermore the theory behind the measurements is well understood and has led to 
important advances in analyzing the data as I described in Chapter 3. The demonstration of these 
tools and analysis methods on various applications has shown that QPI can serve as an important 
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tool in biological imaging. However, the exploration of biological applications has remained 
shallow and thus QPI methods have so far failed to gain a foothold as an indispensable tool in 
any scenario. The goal of my thesis was thus to explore various applications of QPI in detail and 
prove that QPI measurements provide biologically relevant information that is unobtainable with 
any other method. In accomplishing this goal I have developed new hardware and analysis tools 
and made several discoveries. In each application area that I explored, I have demonstrated how 
QPI can be used to complement existing methods and also identified future areas of study that 
would not be possible with any existing method.  
The first application that I explored was using QPI for red blood cell cytometry (Chapter 
4). The goal of this work was to develop a highly sensitive and extremely stable point-of-care 
blood screening tool that has the capability to be deployed in field settings. While working on 
this instrument I also developed new analytical tools that characterize the morphology of 
individual red blood cells and connect this information to various commonly observed 
pathological conditions. The combination of the new imaging tool and analysis has the potential 
to quantify and automate blood smear analysis. This would save money in terms of reagents and 
time spent on analysis while also providing previously unavailable quantitative morphological 
information. I later validated this approach in the clinic in a trial involving 32 patients that 
compared the parameters that are common between my analysis and those available from a 
clinical hematology analyzer. This trial established that my method is both more sensitive than 
the currently used clinical tools and also provides additional clinically relevant information. In 
my work on morphological analysis of red blood cells I realized that one parameter that was 
consistently ignored by others working in the field is the single-cell hemoglobin concentration. 
To address this problem I developed a new imaging modality that combines micro-absorption 
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spectroscopy with quantitative phase imaging (QPI) to provide oxygenation state, hemoglobin 
concentration and morphological information at the single-cell level [48]. My ground work on 
blood screening is now being followed up by several new members of our and other groups  (42 
citations to my 3 papers as of May 2013), indicating that it is indeed a viable approach, which 
with further effort and development has the potential to transform the practice of 
hematopathology. 
The second application I discussed in Chapter 5 is using QPI to study cell growth at the 
single-cell level. Determining the growth patterns of single cells is still an open and highly active 
area of research with several high impact publications on almost a monthly basis. The reason that 
studying this phenomenon in detail has remained elusive is due to the fact that cells weigh in on 
the order of picograms and only double their mass over their cell cycle, which makes it necessary 
to measure their mass with femtogram accuracy. I showed that such a measurement is possible 
using SLIM and that SLIM is superior to other contemporary methods such as microresonators 
since it has the capacity to measure adherent and non-adherent cells, all different cell types, 
provides simultaneous information on morphology and motility and can easily be combined with 
any other microscope modality such as fluorescence to provide additional dimensions of 
information. I have leveraged all these capabilities in different cell models, establishing SLIM as 
an ideal instrument for studying cell growth with the ability to answer several open, important 
biological questions. My initial work on cell growth was on measuring single E. coli cell and 
their progeny. I found evidence of exponential growth at the single cell which agreed well with 
previous measurements. This study established SLIM as a tool for studying single cell growth. 
Next, I turned my attention to a more complex system, namely human osteosarcoma (U2OS) 
cells. The goal of the study was to develop a method to study cell growth as a function of cell 
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cycle phase. To accomplish this I used an YFP-PCNA transfected version of the U2OS cell line 
that provided information on the cell cycle phase at the single-cell level through simultaneous 
fluorescence imaging. This eliminates the need to synchronize the cell population and allows for 
studying how single cells transition between various phases of the cell cycle. Using this method I 
found that the growth rate varies throughout the life cycle of the cell, with the highest growth 
rate in the G2 phase. This overturns the previous commonly accepted wisdom of constant 
exponential growth patterns.  
It is clear that using QPI  to study cell growth has the capacity to answer many open 
questions such as how cells transition between various phases of the cell cycle, how motility 
adherence and density affect these patterns, the effects of nutrient availability and gradients 
among many others. Answering these questions will have a far-reaching impact on both basic 
knowledge of cell behavior and clinical implications in terms of how various therapeutic agents 
alter growth at the single-cell level. One important potential application of the cell growth 
measurement capabilities is a cell proliferation assay. Since I believe that this application holds 
the highest potential for immediate impact, I explored it in detail by using a model system of 
breast cancer cells.  
In Chapter 6, I showed that SLIM measurements of dry mass can be used as highly 
sensitive cell proliferation assays with several advantages of existing techniques. Namely, the 
SLIM based assays are more sensitive and can thus measure changes in growth at the single cell 
level, compared to the tens of thousands of cells required by currently used assays. The higher 
sensitivity also leads to detection of effects in shorter times. Furthermore, SLIM can be used to 
analyze the heterogeneity within a population and how that affects its response to a drug. Since 
SLIM provides information at the single-cell level and can also measure cell cycle dependent 
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growth, the specific mechanism of drug action may also be determined. In the MCF-7 model 
system I showed that adding estradiol results in increased overall growth resulting from smaller, 
faster dividing cells and that adding an estrogen receptor antagonist results in smaller slower 
cells with long doubling times. This method can be readily adapted to test the response of any of 
the NCI primary screen cell lines to any compound. 
The final application I discussed in Chapter 7 is neural network formation. A neural 
culture is a type of system that lends itself extremely well to the quantitative and highly sensitive 
nature of QPI methods. Using SLIM I investigated self-organization of a network in human stem 
cell derived neural cultures. To accomplish this I adapted various analytical tools that provide 
information on the spatial organization, mass transport characteristics and overall mass growth. 
In the stem cell derived neurons I showed that two phases of growth and development exist and 
they are linked. In particular the mass of the culture grew for 12 hours after which it stabilized, 
once the mass growth was stabilized clear changes in the spatial organization and mass transport 
were observed. Since there is no existing method that provides such information it was difficult 
to put this knowledge in the context of a biological phenomenon. To address this I am now 
conducting controlled studies in which various aspects of the culture environment are modulated 
and the effects are measured using SLIM. In this manner I will establish a link between SLIM 
data and physiological conditions in a neural culture.  
As in the case of neural networks, I believe that the next step for QPI is to integrate with 
existing methods that allow for precise control of the cellular microenvironment. These include 
microfluidics for creating chemical gradients and simulating physiological conditions, substrate 
modification for providing mechanical stimulus, micro-electrodes for stimulation and detection, 
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and of course combing fluorescence microscopy and genetic engineering for examining gene 
expression and cell phenotype.  
In the future I hope to leverage the knowledge and experience I have gained here to solve 
key problems in biology and medicine. Based on the results I have presented in this thesis I 
believe that it is clear QPI can be used in both clinical and research lab settings. As I have 
demonstrated through various applications the unique data acquired by QPI can help improve our 
understanding of any biological system. As biology continues to become a more quantitative 
science I believe that QPI technologies will play an essential role in answering key questions in 
the areas of cell growth, dynamics, organization, differentiation and beyond. 
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APPENDIX A.  LIVE CELL IMAGING METHODS AND MATERIALS 
E. coli 
E. coli MG1655 cells were cultured overnight in LB (Luria Broth). The overnight cultures were 
sub-cultured by dilution (100x) into commercial M9CA media with Thiamine (Teknova M8010). 
After the culture reached an optical density (OD) of ~0.1 the cells were concentrated to an OD of 
~0.4 and 2 µl of cell culture were pipetted onto a glass-bottom dish (In Vitro Scientific D29-20-
1-N). The cells were covered by an agar slab (1.5% Agarose, M9CA media, 1mm thickness), 70 
µL of H2O was pipetted onto the edge of the dish (never in contact with the sample) to mitigate 
drying of the agar. The dish was then covered with a circular cover slip to reduce evaporation, 
and transferred to the microscope for imaging. For the fixed cell measurements 1 ml of ~0.2 OD 
cell culture is centrifuged, the resulting cell pellet is then mixed 1 ml of 3.7% paraformaldehyde 
(Fisher-Reagents p531-100), after 20 minutes the cells are washed with PBS twice (diluted from 
10X stock Teknova p0195). 
For imaging, cells were kept at 37oC with an incubator XL S1 W/CO2 kit (ZEISS catalog 
#1441993KIT010). Time-lapse SLIM images were acquired once a minute with a Zeiss Plan-
Apochromat 63×/1.4 Oil PH3 M27 (ZEISS catalog # 4207819910000). The sample is also 
scanned in z with a slice spacing of 0.280 µm and a total of 10 slices. The exposure time was 35 
ms for each image at full lamp power (3200K, or 10.7V), the transmission shutter was closed 
before and after each scan.  
U2OS 
U2OS cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) containing high 
glucose, supplemented with penicillin-streptomycin and 10% fetal bovine serum 
(Hyclone).  Lipofectamine 2000 (Invitrogen) mediated transfection was carried out in U2OS 
cells as per the manufacturer’s instructions, followed by G418 selection (600µg/ml) to generate 
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the YFP-PCNA stable cell line. For the synchronized population measurements, cells were 
arrested at the G1/S boundary, by adding 2mM thymidine. After 24 hrs, cells were washed thrice 
with fresh medium, grown for 12 hrs, and incubated with 2mM thymidine for an additional 24 
hrs. Cells were then released for live cell imaging. For the fixed cell measurements, cells were 
fixed in 2% formaldehyde for 15 min at room temperature and then washed twice by phosphate-
buffered saline (PBS). 
For the synchronized U2OS measurements, cells were transferred to a "closed" 
cultivation chamber (POC-R cell cultivation system, Zeiss) and kept at 37oC with an incubator 
XL S1 W/CO2 kit (ZEISS catalog #1441993KIT010) and a heating insert P S1/Scan stage 
(ZEISS catalog #4118609020000) in L-15 medium (minus phenol red) containing 30% 
FBS.  The medium was automatically refreshed every 4 hours using a syringe pump (Harvard 
pump 11 plus advanced dual syringe with dual RS-232, Harvard Apparatus) controlled by a 
Labview program developed in house. The pumping rate was set to 150 μl/min and a total of 600 
μl was pumped, which is larger than the volume of the perfusion chamber, to ensure complete 
replacement of the growth media. The imaging details are the same as the cell cycle study 
described below. 
 For the cell cycle study, cells were transferred to MatTek dish (35mm dishes, No.1.5 
glass thickness and 10mm well diameter) and kept at 37oC with an incubator XL S1 W/CO2 kit 
(ZEISS catalog #1441993KIT010) and a heating insert P S1/Scan stage (ZEISS catalog 
#4118609020000) in L-15 medium (minus phenol red) containing 30% FBS. The dish was filled 
with culture medium (7ml) and covered with a cover glass (diameter 42mm) to prevent possible 
evaporation. No noticeable medium loss was observed during the imaging interval of two days, 
due to the cover glass on top of the dish and the continuously supply of moisturized CO2 gas into 
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the chamber. Time-lapse SLIM images were acquired with a Zeiss EC Plan-Neofluar 10×/0.3 
PH1 M27 objective (ZEISS catalog #4203419911000) and the corresponding fluorescence 
images were recorded using a Zeiss EC Plan-Neofluar 40×/0.75 PH2 objective (ZEISS catalog # 
4203619910000). It is important to note that for the SLIM measurements a lower numerical 
aperture was used here in order to ensure that the entire dry mass of the cell is captured as 
explained in detail in the Appendix B and Fig. B.4 and B.5.  Excitation light for the fluorescence 
measurements was provided by a X-Cite 120XL package (120W HBO/Halide fluorescence 
illumination, ZEISS catalog # 4108092050000) and a FITC filter set (ZEISS catalog # 
4236060000000). Every fifteen minutes, the sample was scanned in an 3 × 3 tile pattern to 
achieve a total field of view of 1.2 × 0.9 mm2, while a z-stack of 7 slices was taken with slice 
spacing 4 μm which is optimal selected by ZEISS Axiovision software (ZEISS catalog 
#4101300300000). The exposure time was 8 ms for each image at full lamp power (3200K, or 
10.7V) and the total scanning time for the multidimensional acquisition was 57 seconds. The 
transmission shutter was closed before and after each scan. At least 52 hours of data was 
acquired in this manner for each experiment. The maximal projection was used for the processed 
z-stack phase images in order to minimize the phase oscillatory behavior due to the defocusing 
effect, which is due to either the focus drift of the system or the movement of the cell. The 
fluorescence images were taken every hour in a 6 × 5 tile pattern to get a total field of view 1.2 × 
1.0 mm, centered on 3 × 3 tile pattern. A highly sensitive EMCCD camera (Princeton 
Instruments, PhotonMAX 512B) located at the bottom port of the microscope was used for 
fluorescence image acquisition. The exposure time for each fluorescence image was 60 ms, the 
lamp power was set at 12.5% of the maximum lowest available for X-Cite 120XL (120W 
HBO/Halide fluorescence illumination, ZEISS catalog # 4108092050000) and the total scanning 
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time was 21 seconds. The reflection shutter was controlled by the ZEISS Axiovision software so 
that individual cells were exposed to the excitation light for only 60ms at a time.  A careful 
adjusted reflection illumination field aperture assures only minimum light leakage exists on the 
neighboring cells during mosaic scanning. 
MCF-7 
Commercially available MCF-7 cells were obtained from the American Type Culture Collection 
(Manassas, VA) and were cultured in MEM (Sigma-Aldrich Corp, St. Louis, MO) supplemented 
with 5% calf serum (HyClone, Logan, UT), 100 µg/ml penicillin / streptomycin (Invitrogen, 
Carlsbad, CA), and 25 µg/ml gentamicin (Invitrogen). Cells were then seeded in phenol-red free 
MEM containing 5% charcoal dextran treated calf serum to incubate for 4 days.  Two chamber 
slides (Lab-Tek) with glass bottom coverslips were used to allow for side by side imaging of the 
control and treated samples. The media was changed on day 2 and 4 prior to treatment with the 
control vehicle or ligand treatments (Estradiol (E2, 10 nM) and ICI 182780 (ICI Fulvestrant, 1 
µM)). During imaging the cells were kept at 37 °C and in a 5% CO2 atmosphere with an 
incubator and heated stage insert. Each well was scanned every 30 minutes in a 4x4 tile pattern 
with a Zeiss EC Plan-Neofluar 10×/0.3 PH1 objective providing a total field of view of 1.55 x 
1.16 mm. The exposure time was 15 ms for each image at full lamp power (3,200 K, or 10.7 V). 
For the colorimetric measurements a WTT-assay (Roche, Basel, Switzerland) was used, 
absorbance was measured at 450 nm using a BioRad 680 Microplate Reader. 
Stem cell derived neurons 
Commercially available differentiated human neuronal cells (hN2 from ArunA Biomedical, 
Athens, GA) were used.  Cells were grown in 35 mm Poly-l-lysine coated glass bottom dishes 
(20mm well diameter, MatTek) which were first coated with Matrigel. AB2 Basal Neural 
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Medium was supplemented with ANS supplement (both from ArunA Biomedical), Penicillin-
streptomycin, GlutaMAX (both from Invitrogen) and Lukemia Inhibitory Factor (LIF, from 
Millipore). Cells were moved from the incubator to the imaging system 6 hours after plating. 
During imaging the cells were kept at 37 °C and in a 5% CO2 atmosphere with an incubator and 
heated stage insert (Zeiss). For the 24 hour dataset, the sample was scanned every 10 minutes in 
a 3x3 tile pattern with a Zeiss EC Plan-Neofluar 10×/0.3 PH1 objective providing a total field of 
view of 1.2 x 0.9 mm. The exposure time was 15 ms for each image at full lamp power (3,200 K, 
or 10.7 V). Higher resolution datasets were recorded at 0 and 24 hours using a Zeiss EC Plan-
Neofluar 40x/0.75 at a frame rate of 0.5 Hz for 5 minutes with a 50 ms exposure time.  
Primary Rat Neurons 
Primary postnatal day 1 rat hippocampal neurons were plated in a 35mm poly-L-lysine coated 
glass bottom dish, with a 22mm working diameter (World Precision Instruments).  Neurons were 
grown in Neurbasal-A (Invitrogen) supplemented with L-Glutamine, penicillin/streptomyocin, 
and B27 (Invitrogen).  Media was changed every other day. Cells were imaged once every 24 
hours for 5 days and were incubated in a Forma-Scientific 1000 series water-jacketed incubator 
at 37 °C and in a 5% CO2 atmosphere.  Every 24 hours, the cultures were removed from the 
incubator, imaged, and then returned to the incubator. )). During imaging the cells were kept at 
37 °C and in a 5% CO2 atmosphere with an incubator and heated stage insert. Each well was 
scanned in a 7x7 tile pattern with a Zeiss EC Plan-Neofluar 10×/0.3 PH1 objective providing a 
total field of view of 2.71 x 2.03 mm. The exposure time was 5 ms for each image at full lamp 
power (3,200 K, or 10.7 V). In order to image the same area every day, a marker was placed on 
the bottom of each dish using a permanent marker.  
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APPENDIX B.  SUPPLEMENTARY MATERIALS 
 
Figure B.1. E. coli Volume and Density. (a)Volume Growth Rate vs. Volume  for 20 cells; faint circles 
indicate single data points from individual cell growth curves, dark markers show the average and the 
dashed lines is a linear fit through the averaged data; the slope of this line, 0.011 min-1, is a measure of the 
average growth constant for this population. (b) Volume vs. Dry Mass for the cells shown in a; it can be 
seen that the relationship is linear, indicative of a constant volumetric mass density. 
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Figure B.2. YFP-PCNA for detecting S-Phase. Images show typical DAPI and YFP-PCNA 
fluorescence images at the indicated cell cycle phases. It can be see that S-Phase is clearly recognizable 
from YFP-PCNA signal, whereas the distribution of  the DAPI nuclear stain remains constant throughout 
the cell cycle. 
U2OS Growth During Mitosis 
The kinetics of mass growth during mitosis is extremely interesting and merits further 
investigation, especially because the cell undergoes significant shape changes. For now, in order 
to demonstrate that SLIM can maintain accuracy during such extreme morphological changes, 
we studied the mass change during mitosis. Figure B.3 shows the growth curve for U2OS cells 
undergoing mitosis. As evident in the figure, cell morphology changes drastically during mitosis; 
on the other hand, cell mass continues to grow monotonously during all of mitosis. The cell mass 
is also relatively conserved during prophase, prometaphase and metaphase, where the 
morphology of the cell changes from flat to spherical, which confirms that our measurement is 
robust and not susceptible to drastic changes in cell morphology. For the cells shown in Fig. B.3, 
the measured growth rate is 1.6 pg/min. We hypothesize that, while this change in cell geometry 
does not affect our optical measurement, it must play an important role in cell growth regulation 
since the rounding up and flattening down of the cell takes place with significant changes in the 
ratio of the volume to the surface area. It is apparent in our SLIM data that occasionally cells 
G1 Early S Mid S Late S G2
YFP-PCNA
DAPI
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release micron-size vesicles (blebs), which potentially can function as negative feedback for cell 
growth and would be an interesting direction for future research. 
 
Figure B.3. SLIM measurement of U2OS mass change over mitosis. Blue dot lines show 8 mitotic 
cells and the red solid line shows their average.  All the cells have been synchronized according to the 
metaphase a posteriori. Colorbar indicates dry mass density in pg/m2. Scale bar: 20m.  
Measuring the integrated phase delay through a thick object 
When measuring thick objects such as the U2OS cells shown in this thesis, it is important to 
consider the depth of field of the objective being used. In order to ensure that the phase that we 
measure is the axially-integrated phase delay through the cell, we used a 10x/0.3 NA objective 
which has a depth of field of ~8.2 microns according to the manufacturer (ZEISS catalog 
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#4203419911000).  Furthermore in order to compensate for possible focus drifts , we also 
perform a z-scan and project the maximum phase value, as detailed in Appendix A.  
In order to estimate the U2OS cell thickness, we used three different methods: high-NA 
SLIM (Fig. B.4a) and deconvolution fluorescence microscopy (Fig. B.4 b, c). The fluorescence 
measurements were taken with a DeltaVision microscope using an Olympus 60x/1.42 oil, Plan 
Apo N objective (UIS2,1-U2B933) and a CoolSnap (HQ2-ICX285) camera. Figure B.4b shows 
the YFP-PCNA marker and Fig. B.4e shows a cytoplasmic (tubulin) YFP-Stain. These 
measurements show that a typical cell is between 7-8 µm thick, which is within the depth of field 
of the 10x objective being used. 
To demonstrate that the 10X/0.3 NA objective is indeed sufficient to accurately measure 
U2OS cells we measured 7 µm silica beads immersed in 50 % glycerol by weight in water (Fig.  
B.5 a and b). The refractive index difference between the beads (1.431) and the glycerol solution 
(1.401) is 0.03, as provided by the manufacturers. Thus, the expected phase delay is 2.489 
radians, which agrees very well with our measured value of 2.49.  Furthermore Fig. B.5c shows 
that the even if the object is located 4.08 m above or below the focus, the error in phase is only 
0.6 %. For the planes 12.24 m below and 9.16 m above the focus, the error is 6.8%. This 
indicates that our phase integration is around 20 m for weakly scattering objects such as the 
cells we are measuring.  
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Figure B.4. U2OS Cell Thickness. (a) SLIM measurement of a U2OS cell showing that that thickness is 
approximately 7.6 µm, measured from when the membrane is first visible at 2.4 μm, to the last particle in 
focus on top of the cell at 10 microns; color bar is in radians; scale bar: 8 μm. (b-c) Deconvolution 
fluorescence images also showing that the 4 cells imaged are approximately 7 μm in thickness, (b) YFP-
PCNA measured from when the membrane is first in focus at 4 μm to when the last piece of the nucleus is 
in focus at 11 μm, (c) Cytoplasmic (tubulin) YFP stain measured from when the membrane is first in 
focus at 3 μm to the last in focus image at 10 μm. Scale bars: 30 μm, white arrows indicate particles or 
areas of the membrane that are in focus. 
a z=2.4 µm z=6.2 µm z=10 µm
z=4 µm z=11 µmz=7 µmb
z=3 µm z=10 µmz=6 µm
c
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Figure B.5. Measuring the integrated phase delay. (a) 7 μm beads immersed in a mixture of 50% 
glycerine by weight with water. Scale bar: 10 μm. Colorbar indicates phase shift in radians. (b) Histogram 
of the selected area in (a) showing that the phase shift is close to the expected value of 2.4896. (c) Mean 
value of the central area of the bead (dotted circle in (a)) as a function of position in z. It can be seen that 
the error for the two slices 4.08 m above and below the focus is less than 0.6%, and for the slices 12.24 
m below and 9.16 m above is just 6.8%. 
 
 
Figure B.6. Thresholding for removal of reminiscent halo artifact. Images show a typical cell image 
before and after setting negative phase values to zero. The graph shows a comparison of the histograms of 
the two images. These values were removed in order to prevent underestimation of the cell dry mass. 
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Figure B.7. Comparison with phase contrast and effects of halo. (a) Phase images at two points from a 
typical E. coli colony. SLIM is the raw phase image, No –ve is with halo remove as shown in Fig. B.6, 
Halo is map with positive values removed, scale bar is 2.5 µm. (b) Corresponding Phase contrast images. 
It can be seen that halo is noticeably worse. (c) Line profiles (through dotted line in (a)) for SLIM and PC 
images, it can be noted that the halo is significantly reduced in the SLIM image. (d) Comparison of 
growth curves with and without halo removal; without halo removal no growth can be observed in the PC 
data. The slopes of the non-negative and untreated SLIM data are identical. (e) Normalized growth clearly 
illustrating the advantage of SLIM measurements over PC. 
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MCF-7 Estrogen experiments 
 
Figure B.8. E2 vs. Veh growth. (a) Average dry mass (left axis, solid lines) and WST-1 assay data (right 
axis, dashed lines). (b) Growth rate vs. Time, a significant shift between E2 and Veh can be seen at 10 
hours. 
 
Figure B.9. Growth data for all clusters. (a) Normalized mass vs. Time for all clusters that were 
analyzed. (b) Normalized area vs. time for all clusters. (a-b) Dotted lines show individual cluster data and 
solid lines show averaged data. Dashed lines indicate where the differences between groups becomes 
significant.  
 
Figure B.10. Sensitivity of dry mass measurement. Due to debris in the field of view, the noise in the 
mass measurement is higher (~pgs) than SLIM’s capabilities (~fgs) 
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APPENDIX C.  SLIM DESIGN DETAILS  
The SLIM setup is based on a Zeiss Axio Observer Z1 motorized inverted research imaging 
microscope which optimized for bright-field, phase, DIC and fluorescence contrast techniques. 
Axio Observer Z1 base (ZEISS catalog # 431007901000) includes motorized focus drive 
(minimum step width 10nm), TFT touch screen, motorized 3-position optovar turret, keys for 
switching TL/RL illumination, circular operation key unit right and left, light and contrast 
manager, interfaces 4X CAN RS232, USB, and TCP/IP, trigger socket (In/Out) for shutter and 
connecting socket for external uniblitz shutter. A three position beam splitter (ZEISS catalog # 
4251540000000) allows to redirect light to left port (SLIM), right port (DPM) or front port of the 
microscope. The epi-fluorescence components include X-Cite 120XL package (120W 
HBO/Halide fluorescence illumination, ZEISS catalog # 4108092050000), FL/HD light train 
observer (ZEISS catalog # 4236060000000), six position motorized turret (ZEISS catalog # 
4249470000000), 31000DAPI/HOECHST set (ZEISS catalog #4108121005000) and CZ917 
FITC filter set (ZEISS catalog # 4108121203000). The transmitted light path is equipped with 
tilt-back illumination carrier (ZEISS catalog #4239200000000), a lamp housing (12V 100W with 
collector, ZEISS catalog #4230000000000), a bulb (12V 100W Hal, square filament, ZEISS 
catalog #3800799540000), an interface F/0.55 motorized shutter (ZEISS catalog 
#4239210000000) that enables SLIM, phase contrast or DIC image overlays with single or 
multichannel fluorescence image acquisitions, and motorized LD Condenser 0.55 with bright 
field, Ph1, Ph2, Ph3, DIC and aperture diaphragm (ZEISS catalog #4242440000000). 
Objectives used for this study are Zeiss EC Plan-Neofluar 10×/0.3 PH1 M27 (ZEISS 
catalog #4203419911000), Zeiss EC Plan-Neofluar 40×/0.75 PH2 (ZEISS catalog # 
4203619910000) , and Zeiss Plan-Apochromat 63×/1.4 Oil PH3 M27 (ZEISS catalog # 
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4207819910000). The intermediate image right after the objective and tube lens has been 
directed to left port for SLIM, phase contrast and epi-fluorescence imaging. 
In order to match the illumination ring and the size of the LCPM, the intermediate image 
is relayed by a 4f system with a focal length 150mm doublet (Thorlabs, AC508-150-A1-ML) and 
a focal length 200mm doublet (Thorlabs, AC508-150-A1-ML). Fourier lens L1 (doublet with 
focal length 300mm, Thorlabs, AC508-300-A1-ML) and Fourier lens L2 (doublet with focal 
length 500mm, Thorlabs, AC508-500-A1-ML) forms another 4f system. The LCPM (array size 
7.68mm×7.68mm, Boulder Nonlinear, XY Phase series, Model P512-0635) is placed at the back 
focal plane of L1 and thus overlays the back focal plane of the objective and the illumination 
ring. A polarizer (Edmund Optics, Stock # NT47-316) is placed in front of the LCPM to make 
sure it works in phase modulation mode. The camera is ZEISS AxioCam MRm (1388×1040 
pixels, pixel size 6.45μm×6.45μm, ZEISS catalog #4265099901000).  
Overall, SLIM has an additional 2.22× magnification outside the microscope. For a 40× 
objective, the overall magnification will be 88.89×, which results in 13.78 pixels/μm in the 
image plane. Thus, our CCD is oversampling the diffraction spot by a safe margin. The 
microscope is equipped with live cell environmental controls optimized for 4+ hour time studies, 
including incubator XL S1 W/CO2 kit (ZEISS catalog #1441993KIT010), heating insert P 
S1/Scan stage (ZEISS catalog #4118609020000) and POC-R Cell cultivation system. The whole 
microscope is controlled by Axiovision (ZEISS catalog #4101300300000) with multi-channel, 
time-lapse, mosaic and Z-stack acquisition. The LCPM is controlled by the Labview based 
software development kits (Boulder Nonlinear). A data acquisition system based on Labview 
(National Instruments) and NI-DAQ (National Instruments, NI USB-6008) is also developed in 
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house to synchronize the LCPM and Axiovision. Matlab and ImageJ are used for phase image 
processing and visualization.  
  
138 
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1. M. Mir, B. Bhaduri, R. Wang, R. Zhu and G. Popescu, “Quantitative Phase Imaging,” 
Progress in Optics, Chennai: B.V.; (2012), pp. 133-217 (invited) 
JOURNAL PUBLICATIONS 
Under review and in preparation 
1. *M. Mir, A. Majumder, M. Xiang, R. Wang, S. C. Liu, M. U. Gillette, S. Stice and G. 
Popescu, “Emergent properties of a forming neuronal network,” Sci. Rep (under review) 
2. T. Kim†, R. Zhou†, M. Mir, S. D. Babacan, P. S. Carney, L. L. Goddard, and G. Popescu, 
“White Light Diffraction Tomography,” Nat. Phot. (under review) 
3. G. Popescu, K. Park, M. Mir, and R. Bashir, “Weighing on Cells” (Commentary), Nat. 
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4. *M. Mir, A. Bergamaschi, B.S. Katzenellenbogen and G. Popescu, “Effects of estrogen, ICI 
and tomaxifen on breast cancer growth at the single cell level” (in preparation) 
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